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ABSTRACT  
   
 The development of the vertebrate musculoskeletal system is a highly dynamic 
process, requiring tight control of the specification and patterning of myogenic, 
chondrogenic and tenogenic cell types. Development of the diverse musculoskeletal 
lineages from a common embryonic origin in the paraxial mesoderm indicates the 
presence of a regulatory network of transcription factors that direct lineage decisions. 
The basic helix-loop-helix transcription factor, PARAXIS, is expressed in the paraxial 
mesoderm during vertebrate somitogenesis, where it has been shown to play a critical 
role in the mesenchymal-to-epithelial transition associated with somitogenesis, and the 
development of the hypaxial skeletal musculature and axial skeleton. In an effort to 
elucidate the underlying genetic mechanism by which PARAXIS regulates the 
musculoskeletal system, I performed a microarray-based, genome-wide analysis 
comparing transcription levels in the somites of Paraxis-/- and Paraxis+/+ embryos. This 
study revealed targets of PARAXIS involved in multiple aspects of mesenchymal-to-
epithelial transition, including Fap and Dmrt2, which modulate cell-extracellular matrix 
adhesion. Additionally, in the epaxial dermomyotome, PARAXIS activates the expression 
of the integrin subunits α4 and α6, which bind fibronectin and laminin, respectively, and 
help organize the patterning of trunk skeletal muscle. Finally, PARAXIS activates the 
expression of genes required for the epithelial-to-mesenchymal transition and migration 
of hypaxial myoblasts into the limb, including Lbx1 and Met. Together, these data point 
to a role for PARAXIS in the morphogenetic control of musculoskeletal patterning. 
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Chapter 1 
Introduction 
 
The development of the vertebrate musculoskeletal system is an intricate and 
highly dynamic process, resulting in the proper organization and function of the bone, 
cartilage, tendon and skeletal muscle of which it is composed (Watkins, 2009). However, 
due to the enormous complexity inherent in the development of a system comprised of 
multiple tissue types, it is no surprise that even the slightest disruption can result in 
devastating congenital defects. The muscle degeneration characteristic of Duchenne 
Muscular Dystrophy, or the vertebral fusions present in patients with spondylocostal 
dysostosis, can be caused by the mutation of individual genes that are expressed in the 
progenitor tissue of muscle and bone (Bulman et al., 2000; Dickson et al., 1992; Ervasti 
and Campbell, 1993; Hoffman et al., 1987). While the determinants of a few disorders of 
the musculoskeletal system have been identified, our knowledge of the genetic pathways 
involved in the specification, differentiation and localization of its diverse cell types is far 
from complete. The activation or repression of the genes critical for these processes is 
often modulated by DNA-binding transcription factor proteins. Transcription factors 
control multiple aspects of embryonic development, and can function as “master 
regulators” of developmental programs. The study of transcription factor activity, within 
the context of the developing vertebrate embryo, is therefore critical to the pursuit of a 
complete understanding of the development and diseases of the musculoskeletal system. 
The focus of the work presented here is the characterization of the role of the basic-helix-
loop helix (bHLH) transcription factor PARAXIS (TCF15) in the development of the 
tissues of the musculoskeletal system. An appreciation of the origins of these tissues is 
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necessary for an informed examination of the role of PARAXIS during embryonic 
development.  
 
The formation of the somites 
 One of the defining characteristics of the vertebrate body plan is a metamerically-
arranged axial skeleton encasing the central nervous system (Smith et al., 2013). This is 
reflected in muscles associated with the ribs and vertebrae, including the erector spinae, 
serratus, and intercostal muscles (H. Shinohara, 1999). The axial skeleton, skeletal 
muscle and tendon comprising the musculoskeletal system derive from a common origin 
in the vertebrate embryo, the paraxial mesoderm, and the metamery displayed by these 
tissues is the result of a transient restructuring of the paraxial mesoderm within the 
embryo to produce the somites (Meier, 1984). Somites are paired, epithelial spheres of 
cells situated on either side of the neural tube, the midline structure that will eventually 
form the spinal cord (Figure 1). Christ and Ordahl (1995) proposed a somite staging 
system to standardize the comparisons made between different age embryos, such that 
the somites are enumerated in a posterior-anterior direction with roman numerals. The 
formation of the somites imposes a segmental organization not only on somite-derived 
tissues, but also on the developing nervous system and vasculature (Bronner-Fraser and 
Stern, 1991; Kalcheim and Teillet, 1989; Keynes and Stern, 1984; Stern and Keynes, 
1987; Teillet et al., 1987). The segmentation of the somites within the paraxial 
mesoderm, a heavily studied process termed somitogenesis, begins at the anterior end of 
the embryo and moves towards the posterior end, repeating at regular, species-specific 
intervals (Gomez et al., 2008).   
Somitogenesis is dependent upon three distinct, yet interrelated, processes 
required to (1) determine the timing of boundary formation, (2) establish the site of 
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Figure 1. The tissues of the musculoskeletal system are derived from a common 
embryonic origin. Beginning at the anterior end of the embryo, the presomitic mesoderm 
is periodically segmented and epithelialized in a mesenchymal-to-epithelial transition to 
form the somites. The epithelialization of the somites is critical to the pattering of its 
derivatives. Maturing somites then undergo multiple rounds of epithelial-to-
mesenchymal transition to form the tissue-specific somitic compartments. The 
sclerotome will give rise to the axial cartilage and bone and the syndetome will give rise 
to tendon. The dermomyotome will give rise to the myotome, which will form skeletal 
muscle. The remaining dermomyotome will give rise to the dermis, adipocytes and 
endothelial cells.  
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boundary formation and (3) undergo a morphological change from a mesenchyme to an 
epithelium. These processes are regulated by distinct tissues, signaling factors and 
genetic pathways (recently reviewed in Dequéant and Pourquié, 2008; Maroto et al., 
2012; Saga, 2012). A model to explain the mechanism underlying the first two processes 
was first proposed in the 1970s as the “clock and wavefront model” (Cooke and Zeeman, 
1976). The “clock” refers to the segmentation clock, or the oscillating gene expression 
that controls the length of the interval between the segmentation events of adjacent 
somites, which was initially described in the avian embryo (Palmeirim et al., 1997) and 
subsequently observed in mouse (Forsberg et al., 1998), zebrafish (Holley et al.) and 
Xenopus (Li et al., 2003) embryos, as well. Cells in the posterior presomitic mesoderm 
(PSM) of the mouse embryo synchronously activate the expression of Notch pathway 
genes, including the Drosophila Delta-homologue Dll1 (Maruhashi et al., 2005), the 
hairy and enhancer of split genes Hes1, Hes5, Hes7 (Bessho et al., 2001; Dunwoodie et 
al., 2002; Jouve et al., 2000), lunatic fringe (Lfng) (Forsberg et al., 1998), and the 
intracellular domain of the NOTCH receptor, itself (Morimoto et al., 2005). The 
expression of these genes in posterior cells leads to their activation in neighboring cells 
to the anterior, such that the expression is propagated autonomously from the posterior 
PSM towards the site of somite formation near the anterior end of the PSM (Palmeirim 
et al., 1997). At the same time, the posterior cells repress the expression of the Notch 
pathway genes through a negative feedback loop involving Hes7 and Lfng, producing a 
wave of gene expression that cycles with rhythmic periodicity (Bessho, 2003; Dale et al., 
2003; Morimoto et al., 2005). Recently, genes in additional signaling pathways have 
been implicated in the segmentation clock and are also expressed in a cyclical pattern, 
including Axin2 and Dkk1 in the Wnt pathway (Aulehla et al., 2003; Dequeant et al., 
2006), as well as the fibroblast growth factor (FGF) signaling components Spry2 and 
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Dusp6 (Dequeant et al., 2006). The mechanisms by which these pathways interact with 
each other to generate a “pacemaker” that regulates the initiation and timing of 
oscillatory gene expression have not yet been fully characterized (Dequéant and 
Pourquié, 2008). It was recently discovered that the pace of oscillating expression in the 
PSM is species-specific, and that it is more rapid in organisms that must form a large 
number of segments (Gomez et al., 2008).  
 The “wavefront” is a positional cue that directs cells within the anterior PSM to 
segment at a distinct axial level, called the determination front (Dubrulle et al., 2001). 
The determination front is defined by the confluence of an anterior-posterior gradient of 
retinoic acid (RA) activity originating at the anterior end of the paraxial mesoderm, and 
a posterior-anterior gradient of both FGF8 and nuclear localized β-CATENIN that 
originates in the posterior PSM (Aulehla et al., 2003; Diez del Corral et al., 2003; 
Dubrulle et al., 2001). Cells that pass through the determination front are thought to be 
competent to begin segmentation with each pulse of the segmentation clock (Dubrulle et 
al., 2001). Experimental manipulation of the FGF8 gradient alters the location of the 
determination front and therefore the number of cells that have passed through it, 
leading to the formation of somites of irregular size (Dubrulle et al., 2001; Sawada et al., 
2001).  
 The final events required for the formation of a somite are the morphological 
transitions that accompany the segmentation and epithelialization of cells at the anterior 
border of the PSM. In addition to the segmentation clock, the physical separation of the 
newly forming somite is also regulated by the oscillating activation of Notch (Saga et al., 
1997). When high levels of Notch intracellular domain (NICD) reach the anterior PSM, 
NICD and TBX6 combine to activate the expression of the transcription factor MESP2 
(Oginuma et al., 2008; Yasuhiko, 2006). Mesp2 is expressed in a one-somite wide stripe 
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just anterior to the determination front (Saga et al., 1997), and is thought to induce 
segmentation through the regulation of the cell adhesion and repulsion receptor EPHA4 
(Nakajima, 2006; Watanabe et al., 2009). EphA4 which is expressed in the anterior half 
of somite S-1 binds to its receptor, ephrinB2, expressed on the neighboring cells in the 
posterior half of somite S0, activating a bi-directional signaling cascade that leads to the 
repulsion of the neighboring cells and the separation of somite S0 from somite S-1 within 
the anterior PSM (Watanabe et al., 2009).  
  
Mesenchymal-epithelial transitions in somitogenesis 
 Concurrently, the cells around the exterior of the newly forming somite undergo a 
morphological transition from a loose mesenchyme to a compact, epithelial sphere. This 
transition is characterized by increased cell-cell adhesion and cell-extraceullar matrix 
(ECM) interaction, the decreased motility of individual cells, and the establishment of an 
epithelium with apicobasal polarity that surrounds a persistent mesenchymal core, the 
somitocoel (Bellairs, 1979; Duband et al., 1987). The somitic mesenchymal-to epithelial 
transition (MET) is the least-well studied aspect of vertebrate somitogenesis, yet it is 
critical to the survival of the organism.  Indeed, mouse embryos that do not undergo 
somitic MET die shortly after birth, due to a severe disorganization of the somite-derived 
adult tissues of the musculoskeletal system (Burgess et al., 1996).  
The initial stages of somitic MET require cytoskeletal rearrangements that direct 
the localization and formation of tight and adherens junctions on the lateral and apical 
surfaces of cells that will form the somitic epithelium (Duband et al., 1987; Glazier et al., 
2008; Kimura et al., 1995; Linask et al., 1998). Cytoskeletal reorganizations also control 
the formation of focal adhesions between the somite epithelium and the extracellular 
matrix (ECM) surrounding the PSM, such that the cells can adhere to, and modify the 
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organization of, the ECM (Jacob et al., 1991; Lash, 1985; Lash et al., 1984). This 
interaction of somites with the ECM is critical to the maintenance of an epithelial state in 
zebrafish and mouse embryos ((Girós et al., 2011; Julich et al., 2009; Koshida et al., 
2005).  
  MET in mouse paraxial mesoderm is initiated by changes in gene expression 
within the PSM that are induced by signaling molecules from the surface ectoderm 
overlying it (Correia and Conlon, 2000; Rifes et al., 2007; Šošić et al., 1997). Indeed, 
when the surface ectoderm dorsal to the PSM is removed, epithelial somites fail to form 
(Correia and Conlon, 2000). This induction of MET in the PSM requires the bHLH 
transcription factor, PARAXIS (Burgess et al., 1996; Linker, 2005). The mechanisms by 
which PARAXIS controls somitic MET, however, have not yet been elucidated. Somite 
epithelialization, and the role of PARAXIS in this mesenchymal-to-epithelial transition 
will be discussed in further detail in Chapter 2. 
  
Maturation of the somites 
The epithelial somite will mature into four recognized compartments: the 
dermomyotome, the myotome, the sclerotome and the syndetome that will are the 
anlagen for the dermis, skeletal muscle, bone/cartilage, and tendons, respectively 
(reviewed in Brand-Saberi et al., 1996b; Brent, 2002; Christ and Ordahl, 1995). The 
morphological formation of these compartments occurs through sequential EMT in 
response to signals from the surrounding tissues.  Disruption of this process leads to 
altered metameric organization of the axial musculoskeletal system and the associated 
peripheral nerves and vasculature.   
The sclerotome is the first somitic compartment to form in response to Sonic 
Hedgehog (Shh) and Noggin expressed in the notochord and the floor plate of the neural 
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tube (Christ and Wilting, 1992; Christ et al., 2000; Christ et al., 1978). Cells in the 
ventro-medial portion of the epithelial S-III somite begin to express Pax1 and undergo 
an EMT to migrate towards the notochord (Brand-Saberi et al., 1993a; Ebensperger et 
al., 1995; Fan and Tessier-Lavigne, 1994; McMahon et al., 1998). The medially 
positioned sclerotome cells from one somite meet the medially positioned sclerotome 
cells from the contralateral somite and surround the notochord to form the anlagen of 
the vertebral bodies (Christ and Wilting, 1992). The lateral sclerotome cells migrate 
dorsally and laterally to ultimately form the neural arches, pedicles and proximal ribs 
(Christ and Wilting, 1992).  
At somite stage SXVI, the most dorso-lateral cells of the sclerotome differentiate 
into a more recently described compartment: the syndetome (Brent et al., 2003). The 
syndetome is comprised of cells that will give rise to tendons, and it forms in the space 
between the future cartilage and muscle with which it will eventually connect.  FGF and 
TGFβ signaling are required to specify and maintain cells in the syndetome lineage.  This 
includes promoting expression of the bHLH transcription factor Scleraxis (Scx) and 
tendon-specific differentiation markers including Fibromodulin (Fmod), Tenomodulin 
(Tmod) and Mohawk (Mkx) (Brent et al., 2003; Ito et al., 2010; Shukunami et al., 2006; 
Svensson, 1999).  
During the EMT of the sclerotome, the dermomyotome, a sheet of cells from the 
dorso-lateral aspect of the somite, remains epithelialized in response to Wnt signaling 
from the surface ectoderm and neural tube and its cells express the paired-box 
transcription factor PAX3 (Brent, 2002; Scaal and Christ, 2004). The dermomyotome is 
a population of self-renewing cells that are the source of the progenitor cells for a wide 
variety of tissues, including skeletal muscle, satellite cells, the dermis of the back, 
interscapular brown fat, scapular cartilage and blood vessels of the body wall, limbs and 
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aorta (Atit et al., 2006; Christ et al., 1983; Gros et al., 2005; Huang et al., 2000; Kardon 
et al., 2002; Kassar-Duchossoy, 2005; Mauger, 1972; Pardanaud et al., 1996; Relaix et 
al., 2005; Venters and Ordahl, 2002; Wilting et al., 1995). The first cells to exit the 
dermomyotome form the myotome, which is the source of all of the skeletal muscle in 
the vertebrate embryo (Huang and Christ, 2000; Ordahl and Le Douarin, 1992).  
 
Development of the skeletal muscle of the trunk and limb 
The myotome is formed from cells that exit the dermomyotome to occupy the 
space between the dermomyotome and the newly mesenchymal sclerotome 
compartment (Buckingham, 2006; Hollway and Currie, 2005; Scaal and Christ, 2004). 
The myotome abuts the apical surface of the dermomyotome epithelium, and is 
separated from the sclerotome by a basement membrane (Anderson et al., 2009; 
Thorsteinsdóttir et al., 2011). Cells entering the myotome from the dors0-medial lip 
(DML) of the dermomyotome will give rise to the deep, epaxial skeletal muscles of the 
back, while cells entering the myotome from the ventro-lateral lip (VLL) will give rise to 
the hypaxial muscles of the ventral body wall, neck and appendages (Gros et al., 2004). 
Many studies have addressed the formation of the myotome in both chick and 
mouse embryos, and the results have led to the development of multiple models 
describing the morphogenesis of the primary myotome (Cinnamon et al., 1999; 
Denetclaw et al., 1997; Hollway and Currie, 2005; Kahane et al., 1998; Scaal and Christ, 
2004). A more recently proposed, unifying model suggests that pioneer myoblasts 
delaminate from the DML, migrate subjacently to enter the myotome and elongate 
bidirectionally towards the anterior and posterior ends of the dermomyotome (Gros et 
al., 2004). In the mouse embryo, these cells are induced to migrate out of the 
dermomyotome by a combination of signaling from the notochord, the dorsal neural 
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tube and the lateral plate mesoderm (LPM). An asymmetric cell division, in which one 
daughter cell sequesters the Notch-inhibitory protein Numb and enters the myotome, 
and the other daughter cell remains within the dermomyotome, is thought to be the 
mechanism by which the delamination is initiated (Holowacz et al., 2006; Venters and 
Ordahl, 2005). Migrating myoblasts bind laminin in the ECM and organize it into a basal 
lamina, restricting the migration of subsequently delaminating cells to the myotome 
compartment (Bajanca, 2006).  
According to the Gros et al. (2004) model, the pioneer myoblasts within the 
myotome are soon joined by myoblasts delaminating from all four edges of the 
dermomyotome. Cells entering from the VLL elongate bidirectionally towards the 
anterior and posterior ends of the myotome (Gros et al., 2004). Myoblasts that enter 
from either the anterior or posterior ends elongate unidirectionally to meet the opposite 
end (Gros et al., 2004). In mouse embryos lacking PARAXIS, elongation of myoblasts 
towards the anterior and posterior borders of the dermomyotome is severely disrupted, 
and can be visualized with a transgene labeling cells that express the muscle 
differentiation transcription factor MYOGENIN (Wilson-Rawls et al., 1999). The 
expression of Myogenin and other muscle-specific transcription factors at this stage of 
myotome formation initiates the process of myogenic differentiation and is required for 
myoblast survival, the activation of muscle structural genes and the fusion of myoblasts 
into myotubes (Hasty et al., 1993; Nabeshima et al., 1993; Sassoon et al., 1989).  
 The second phase of myotome development is characterized by its growth due to 
the addition of myoblasts from the VLL and from regions other than the dermomyotome 
lips (Hollway and Currie, 2005). Dermomyotomes at inter-limb axial levels expand 
ventrally from the VLL into the somatopleure to generate the hypaxial muscle masses of 
the ventral body wall, such as the intercostal muscles (Cinnamon et al., 1999). Under the 
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control of PAX3, myoblasts entering the myotome from the VLL begin to express the 
muscle regulatory factor MYOD, which correlates with the expression of muscle 
structural genes such as embryonic Myosin Heavy Chain (Borycki et al., 1999; Brunelli et 
al., 2007; Hu et al., 2008; Sassoon et al., 1989; Tajbakhsh et al., 1997). In embryos 
lacking PARAXIS, the expression of MyoD in the hypaxial myotome is delayed, and Pax3 
expression is reduced, indicating that PARAXIS expression is required for the 
specification of these myocytes (Wilson-Rawls et al., 1999). The central dermomyotome, 
which contains cells that express both Pax3 and Pax7, undergoes an EMT, with some of 
the cells contributing to the myotome and others adopting dermal or angiogenic fates, 
while the DML and VLL remain epithelial (Tajbakhsh and Buckingham, 2000; Venters 
and Ordahl, 2002). Cells of the central dermomyotome undergo an asymmetric cell 
division in which the cell adhesion protein N-CADHERIN is segregated into only those 
cells that will contribute to the myotome (Ben-Yair, 2005). Myoblasts continue to 
express N-CADHERIN within the myotome, where it helps to maintain the integrity of 
the compartment (Cinnamon, 2006; Delfini et al., 2009; Deries et al., 2010; Inuzuka et 
al., 1991). Finally, the persistently epithelial DML and VLL undergo EMT and the 
dermomyotome disperses, due to an inhibition of surface ectoderm-derived Wnt 
signaling (Geetha-Loganathan, 2006). 
 Prior to the ventral extension of the hypaxial myotome, myogenic progenitor 
cells (MPCs) in the VLL delaminate from the dermomyotome and begin distinct, long-
range migrations (reviewed in Bothe et al., 2007; Buckingham, 2006; Evans et al., 
2006). MPCs from the most anterior (occipital) somites will give rise to cells that migrate 
ventrally and anterior to the developing heart, forming a stream of cells called the 
hypoglossal chord which contains the progenitors of the laryngeal, neck and diaphragm 
muscles (Bladt et al., 1995; Evans et al., 2006; Huang et al., 1999; Noden, 1983). MPCs 
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from dermomyotomes at the level of the forelimb or hindlimb, responding to signaling 
factors from the adjacent limb bud mesenchyme, migrate instead into the limb through 
modifications to cell-ECM interactions (Brand-Saberi et al., 1996a; Heymann et al., 
1996). After progenitor cells have colonized the limb, they proliferate and enter into the 
myogenic differentiation program to form the ventral and dorsal muscle masses of the 
limb that will differentiate into the flexor and extensor muscles of the appendages, 
respectively (Delfini et al., 2000; Duprez et al., 1998; Marcelle et al., 1995; Tajbakhsh 
and Buckingham, 1994). The onset of this differentiation program in the limb is delayed 
in mouse embryos lacking PARAXIS (Wilson-Rawls et al., 1999). However, Paraxis-/- 
neonates are born with normal forelimb muscles, suggesting that there is a mechanism 
by which the embryo compensates for a lack of the transcription factor (Wilson-Rawls et 
al., 1999).  
 
bHLH transcription factor regulation of muscle development in 
vertebrates 
 Much of what we know about the genetic pathways involved in skeletal muscle 
development comes from studies involving the myogenic regulatory factors (MRFs). The 
MRFs include MYF5, MYOD, MRF4 and MYOGENIN, which form the MyoD family of 
basic helix-loop-helix (bHLH) transcription factors (Olson, 1990). The myogenic bHLH 
transcription factors share ~80% amino acid identity within their bHLH domains, which 
are required for DNA binding and dimerization (Olson, 1990).  These transcription 
factor bind hexanucleotide sequences (consensus sequence CANNTG) called E boxes 
(Atchley and Fitch, 1997). The MRFs bind to E boxes found within the promoters and 
enhancers of muscle-specific genes, including their own, that are important for 
determination or differentiation to activate or repress their transcription (Olson and 
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Klein, 1994). BHLH transcription factors utilize the helix-loop-helix domain to dimerize 
with other bHLH proteins prior to DNA binding (Atchley and Fitch, 1997). The MRFs 
often heterodimerize with E proteins, such as the E2A encoded E12 and E47, which are 
ubiquitously expressed, in order to spatially regulate the activation the muscle 
differentiation program (Murre et al., 1989).  
While the MRFs can all induce skeletal muscle development when introduced 
into mesodermal cells in culture (Olson and Klein, 1994), they have overlapping but 
distinct functions in the vertebrate embryo. In mouse embryos, MYF5 and MYOD are 
required for the specification of cells that give rise to the epaxial and hypaxial muscles, 
respectively (Lassar et al., 1989; Ott et al., 1991; Sassoon et al., 1989). Mrf4 is expressed 
in post-mitotic mononuclear myotubes and adult skeletal muscles, rather than in 
myoblasts (Hinterberger et al., 1991), and appears to play a bigger role in regulating 
satellite cell activity in adult muscle than muscle development (Zhang et al., 1995). 
Finally, Myogenin is expressed in elongating myocytes in the myotome and is essential 
for muscle differentiation (Hasty et al., 1993; Nabeshima et al., 1993). The discovery that 
MYOGENIN can both activate, and be activated by, the myocyte-specific enhancer-
binding factor MEF2 suggests that the MRFs do not act alone to initiate and maintain 
the muscle differentiate program, but instead that they participate in a complex 
regulatory network involving positive and negative feedback loops (Cheng et al., 1993; 
Cserjesi and Olson, 1991; Edmondson et al., 1992). 
 
PARAXIS and the development of the musculoskeletal system 
Studies to date have identified additional bHLH transcription factors that direct 
the differentiation of individual tissues of the musculoskeletal system.  While bHLH 
transcription factors were known to play a central role in promoting (MYF5, MYOD, 
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MYOGENIN, MRF4) or inhibiting (TWIST, MYOR, OUT, HES, AND EPICARDIN) 
muscle development, attempts to identify new bHLH family members that regulate the 
specification of somitic cells to the myogenic lineage led to the discovery of two closely 
related bHLH transcription factors, PARAXIS and SCLERAXIS (Burgess et al., 1995; 
Cserjesi et al., 1995; E E Quertermous, 1994).  Phylogenetically, PARAXIS and 
SCLERAXIS are most closely related to TWIST1 and TWIST2, which are known to 
regulate myogenesis, osteogenesis and immune system development. In early mouse and 
chick embryos, these genes have complementary, non-overlapping expression patterns 
in the paraxial mesoderm. PARAXIS transcripts are detected in the presomitic 
mesoderm and epithelial somite, before becoming restricted to the dermomyotome 
(Barnes et al., 1997; Burgess et al., 1995). In contrast, SCLERAXIS is transiently 
expressed in the sclerotome before becoming restricted to the syndetome (Cserjesi et al., 
1995; Schweitzer et al., 2001). Similar patterns of expression have been observed in the 
somites of other vertebrates, such as Xenopus and zebrafish (Carpio et al., 2004; 
Shanmugalingam and Wilson, 1998; Tseng and Jamrich, 2004).  As will be described 
below, PARAXIS appears to be critical for the regulation of the morphological events 
associated with somite MET, muscle differentiation and patterning of the axial skeleton.  
This uniquely positions PARAXIS as a morphogenetic regulator of musculoskeletal 
system in vertebrates.   
Targeted null mutations were used to examine the function of PARAXIS during 
somitogenesis in the mouse embryo.  Segmentation occurred at the normal 
developmental timepoint in the absence of Paraxis, however, the cells maintained the 
loose mesenchymal phenotype of the presomitic mesoderm instead of the canonical 
epithelium of the somite (Burgess et al., 1996).  Genetic markers for the sclerotome, 
myotome, syndetome, and dermomyotome cell lineages were present and expressed at 
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the appropriate time, predicting that the process of specification was not altered in 
mutant embryos.  Postnatally, Paraxis-deficient mice displayed radical deficiencies in 
the axial skeleton, including caudal agenesis fusion and underossification of the 
vertebrate and ribs (Burgess et al., 1996). Further studies revealed a loss of the anterior-
posterior somite polarity required for segmentation of the vertebrate and ribs, 
illuminating a cause for the bone phenotype observed in neonates lacking PARAXIS 
(Johnson et al., 2001; Takahashi et al., 2007).  
 Paraxis is highly expressed in premyogenic cells that populate the DML and VLL 
of the dermomyotome, raising the possibility that the gene contributes to the 
proliferation or differentiation of skeletal muscle.  This hypothesis was supported by the 
absence of the transverse abdominal muscles and hypotrophic intercostals muscles in 
Paraxis-/- neonatal mice (Burgess et al., 1996). In mice deficient for both Myf-5 and 
Paraxis, there is a profound loss of axial hypaxial muscles and a reduction in 
appendicular limb muscles. This demonstrates a role for PARAXIS in the development of 
the hypaxial muscles that is partially compensated by a MYF-5-dependent myogenic 
lineage (Wilson-Rawls et al., 1999).  
 
Regulation of Paraxis Transcription 
Transcription of Paraxis is initiated and maintained by signals from the surface 
ectoderm, dorsal neural tube and tailbud. Removal of the surface ectoderm from the 
caudal PSM results in a loss of Paraxis transcription and a failure of somite 
epithelialization (Correia and Conlon, 2000; Šošić et al., 1997). Maintenance of Paraxis 
expression requires the activation of canonical Wnt signaling, as Wnt6 expression in the 
surface ectoderm induces and maintains somitic MET and Paraxis transcription, and 
ectopic Wnt6 expression is able to substitute for a lack of surface ectoderm in a 
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mechanism that is β-CATENIN dependent (Linker, 2005; Schmidt et al., 2004). 
Furthermore, forced expression of Paraxis is able to rescue somite epithelialization in 
the absence of Wnt signaling (Linker, 2005). These results suggest that PARAXIS 
functions downstream of the Wnt signaling pathway, and that the target genes of 
PARAXIS are necessary to induce MET in presomitic mesoderm. 
 
Downstream Targets of PARAXIS  
Understanding the function of PARAXIS is ultimately linked to identifying its 
transcriptional targets during somitogenesis and myogenesis. These targets have 
remained largely elusive. Several genes important for musculoskeletal development, 
including the paired-box transcription factors PAX1 and PAX3 and the homeobox 
transcription factor MKX, are downregulated in the absence of PARAXIS (Anderson et 
al., 2006; Takahashi et al., 2007; Wilson-Rawls, 2004). However, the direct activation of 
these genes by PARAXIS, has not yet been demonstrated. The results of a recent study 
suggest that PARAXIS functions to prime its target genes for transcriptional activation 
by binding to enhancer elements and activating transcription immediately upon the 
repression of inhibitory proteins (Davies et al., 2013). Like all bHLH transcription 
factors, PARAXIS can bind directly to consensus E Box sequences (CANNTG) as 
homodimers or heterodimers with members of the E12 subfamily (Wilson-Rawls, 2004). 
PARAXIS can bind to, and activate transcription from, a multimerized Ebox found 
within the Scleraxis promoter (Wilson-Rawls, 2004). The significance of this interaction 
remains to be determined as there is little overlap in Paraxis and Scleraxis transcription 
in the embryo (Burgess et al., 1996). Due to the importance of PARAXIS for 
somitogenesis and muscle development, the identification of its direct targets and the 
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genetic pathways in which it functions is critical to our understanding of these processes 
and the prevention of musculoskeletal defects.  
For my dissertation project, I have taken a systematic approach to identifying the 
downstream targets of PARAXIS in the anterior PSM and the first four somites in the 
mouse embryo at E9.5. This represents a tissue that is undergoing MET and thus should 
provide novel insight into the genes critical for the regulation of this process during 
somitogenesis.  As the transition between a mesenchymal and epithelial phenotype plays 
a role in both normal development and malignancies such as metastatic carcinoma, this 
work may also open new avenues for cancer therapies. I will extend my findings 
regarding PARAXIS targets to address PARAXIS’ function in the establishment of the 
myotome and the migration of MPCs into the limbs.  This will help us to understand how 
morphological regulators, such as those associated with MET, may also participate in cell 
migration and organization during myogenesis.  
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Chapter 2 
Regulation of mesenchymal-to-epithelial transition by PARAXIS during somitogenesis 
 
Introduction 
The morphological transition of cells between a mesenchymal and epithelial state 
plays an essential role in the development of complex tissues during embryogenesis, and 
is also associated with the progression of diseases such as cancer and renal fibrosis 
(reviewed in Nieto; Thiery and Sleeman, 2006; Yang and Weinberg, 2008). A notable 
example of mesenchymal-to-epithelial transition (MET) occurs during somite formation 
in vertebrate embryos.  Somitogenesis establishes the metameric patterning of the axial 
musculoskeletal system, in addition to influencing the migration of endothelial and 
neural crest cells that give rise to the vasculature and peripheral nervous system, 
respectively (Burgess et al., 1996; Johnson et al., 2001; Wilson-Rawls et al., 1999). While 
the confluence of signaling pathways that direct the segmentation of somites from the 
anterior presomitic mesoderm (PSM) has been extensively studied, the genetic pathways 
that regulate the concomitant MET have not been well characterized (reviewed in 
Maroto et al., 2012; Saga, 2012). However, somite epithelialization has been shown to 
require the activity of the bHLH transcription factor, PARAXIS (Burgess et al., 1996). 
Identification of genes downstream of PARAXIS has been limited to somite 
compartment makers in the mouse embryo (Takahashi et al., 2007; Wilson-Rawls, 2004; 
Wilson-Rawls et al., 1999), and meox2 in Xenopus (Gaspera et al., 2012). The role of 
PARAXIS in regulating the transcription of genes associated with the archetypal cell 
processes of MET during early somitogenesis remains to be determined.  
Morphologically, MET is initiated by the formation of a two-dimensional sheet of 
cells through the acquisition of primordial cadherin-mediated adherens junctions at the 
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apicolateral borders of adjacent cells (Baum and Georgiou, 2011) (Figure 1). In parallel, 
reorganization of the microtubule cytoskeleton establishes a distinct cell polarity and 
directs the assembly of tight junctions on the apical cell surface of the epithelium (Radice 
et al., 1997; Rhee et al., 2003). Cytoskeletal reorganizations also control the formation of 
focal adhesions between the somite epithelium and the extracellular matrix (ECM) 
surrounding the PSM, such that the cells can adhere to, and modify the organization of, 
the ECM (Jacob et al., 1991; Lash, 1985; Lash et al., 1984). The interaction of somites 
with the ECM is critical to the maintenance of an epithelial state in zebrafish and mouse 
embryos. For example, somitic MET requires the condensation of fibronectin 
surrounding the somite epithelium, which is organized by cell surface proteins on the 
basal surface of the somite epithelium, such as integrin α5 (Girós et al., 2011; Julich et 
al., 2009; Koshida et al., 2005).  
Members of the Rho family of small GTPases (RHOA, RAC1 and CDC42) have 
been shown to be critical for the integration of signals from cell adhesion receptors, 
including cadherins, integrins and Eph receptors, that leads to the reorganization of the 
cytoskeleton required for the formation of adherens/tight junctions and focal adhesions 
during MET (reviewed in Van Aelst, 2002). Studies performed in chick embryos 
demonstrate that RHOA, RAC1 and CDC42 play a role in MET in the somites (Nakaya et 
al., 2004; Takahashi et al., 2005). Nakaya et al. (2004) show that activated CDC42 
promotes a mesenchymal state in the paraxial mesoderm, while activated RAC1 
promotes an epithelial state and is required for PARAXIS-directed epithelialization of 
the somites. These studies predict that PARAXIS participates in a regulatory pathway 
that links canonical Wnt signaling to Rho GTPase activity and the regulation of the 
morphogenetic changes associated with somitic MET. However, this simple pathway  
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Figure 1. Cell-cell and cell-ECM interactions in the epithelial somite. A schematic of the 
organization of cellular and ECM adhesive junctions which are organized during somite 
epithelialization, and the proteins known to be associated with each interaction.  
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does not describe the mechanisms by which PARAXIS regulates its downstream target 
genes to affect Rho GTPase activity and MET in the paraxial mesoderm. 
Here, we use a combination of confocal microscopy and microarray analysis to 
examine somite cell morphology and gene expression in E9.5 Paraxis-/- embryos, as 
compared to wild type embryos.  In the absence of PARAXIS, the cells of the forming 
somite failed to generate the ECM organization associated with MET.  The loss of 
PARAXIS led to the deregulation of modifiers of Rho GTPase activity, but did not alter 
the mRNA levels of RAC1 or other members of the Rho GTPase family directly.  Our data 
also revealed a novel role for PARAXIS in regulating genes that are not associated with 
the canonical GTPase signaling pathway, but are implicated in MET or EMT, including 
those involved in ECM production and stability, cytoskeletal rearrangements via focal 
adhesion and adherens/tight junction assembly, and the non-canonical Wnt pathway.   
 
Materials and Methods 
Animals 
 Mice carrying a null allele for the gene Paraxis (Burgess et al., 1996) were 
maintained as heterozygotes (Paraxis+/-) according to Institutional Animal Care and Use 
Committee guidelines. Embryos were genotyped by duplex PCR on embryo yolk sacs 
using the primers ParaxisWTF: GTCTGGCGTCCAGCTACATC, ParaxisNeoF: 
TGCTCCTGCCGAGAAAGTAT, ParaxisWT/NeoR: GAGCATCAGGCAAGAGGAAG. All 
embryos used in this study were at day 9.5 of gestation.  
 
Microarray Analysis 
 Tissue from the anterior presomitic mesoderm plus somites I-IV was dissected 
from fifteen Paraxis+/+ and fifteen Paraxis-/- embryos in cold PBS, individually flash 
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frozen and stored at -80 °C until genotyping was completed. The tissue was pooled into 
three samples of five embryos per genotype, disrupted by sonication using the Covaris S-
2 system (Covaris; Woburn, MA), and total RNA was extracted with an RNeasy Micro kit 
(Qiagen; Valencia, CA). RNA purity, quantity and integrity were assessed using a 
Nanodrop ND-1000 spectrophotometer (Nanodrop; Wilmington, DE) and an Agilent 
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). 250ng of RNA, with a minimum 
RNA Integrity Number of 7.9 or higher (Bioanalyzer), was used to prepare fluorescent 
cRNA probes using labeling kits and protocols recommended by Agilent. A dye swap was 
performed on each of the three sample groups for both genotypes to account for Cy3- or 
Cy5-conjugated nucleotide incorporation bias. Labeled probes from a reference wild type 
sample and a Paraxis-/- sample were combined and hybridized to dual color 4x44k 
Mouse Gene Expression Microarrays (Agilent, Design ID 014868), according to 
manufacturer’s protocols. Array slides were washed and scanned at 5uM using an Agilent 
Microarray Scanner (model G2505B) in an ozone controlled environment, and data were 
extracted, processed and normalized using Agilent Feature Extraction software (v10.5). 
Genespring GX 10.0 (Agilent) was then used to assign absent, marginal, and present 
annotations. If multiple array probes for a single gene showed consistent deregulation, 
the probe with the highest fold change was used for further analysis. To compare 
expression levels between samples, we used quantile normalization in Genespring to 
minimize technical variation. The microarray data discussed in this publication have 
been deposited at the Gene Expression Omnibus (Edgar et al., 2002) at the National 
Center for Biotechnology Information (NCBI) under GEO Series accession number 
GSE47905 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47905).    
 
Quantitation of Transcription in Embryos 
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 Quantitative RT-PCR (qRT-PCR) was used to confirm the altered expression levels 
of selected genes from each category within Tables 2 and 3. PSM and somite tissue was 
microdissected from Paraxis+/+ and Paraxis-/- embryos, frozen, stored and pooled, as 
stated above. Total RNA was extracted with Trizol reagent (Invitrogen), and converted to 
cDNA with Superscript III (Invitrogen). QRT-PCR was performed on selected genes 
using the ABI Prism 7900HT Sequence Detection System (Applied Biosystems). Cycling 
conditions were 95 °C for 10 minutes, followed by 45 cycles of 95 °C for 15s, 60 °C for 
30s and 72 °C for 30s. Selected genes assayed were normalized to Gapdh expression 
levels. Statistical analysis on expression data was carried out using a nonparametric 
Mann-Whitney test with a p-value of ≤ 0.05. Statistically significant differences in gene 
expression were found for most of the genes tested from Tables 2 and 3, but not for all, 
including Numa1, Pard3 and Dnm3os.  
 
Whole Mount In Situ Hybridization  
Embryos were fixed in 4% PFA overnight, washed in PBSw (0.01% Tween-20 in 
PBS), and dehydrated in a methanol series for storage at -20 °C until use. To generate 
antisense digoxygenin-labeled RNA probes, selected genes were amplified by RT-PCR 
from E9.5 mouse whole embryo cDNA. Gene-specific primers for genes from Tables 2 
and 3 which are known to be expressed in the somites were designed using Primer3 
(Rozen and Skaletsky, 1999) and then modified by adding the T7 RNA polymerase 
binding site sequence (5’-CTAATACGACTCACTATAGGGAGA-3’) to the 5’ end of the 
downstream primer. Generation of digoxigenin-labeled antisense RNA probes and in 
situ hybridization was carried out as described in Johnson et al. (2001). In situ 
hybridization was performed using an automated InsituPro (Intavis, LLC, San Marcos, 
CA), as described previously (Belo et al., 1997). Embryos were photographed using a 
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SMZ1000 stereodissecting microscope (Nikon) with a Retiga CCD digital camera (Q-
Imaging). 
 
Indirect Immunofluorescence 
 For whole mount immunofluorescence, E9.5 embryos were harvested and fixed in 
4% PFA overnight at 4°C, washed in PBSw, and permeabilized for 2 to 3 days in 1% 
Triton X-100 in PBS (PBST) at 4 °C. For section immunofluorescence, fixed embryos 
were embedded, frozen and sectioned as described previously (Anderson et al., 2006). 
Rabbit primary antibodies specific for laminin (Sigma L9393-.2ML, 1:400 dilution), 
EphA7 (Santa Cruz Biotechnologies sc-1015, 1:100 dilution), or FAPα (Santa Cruz 
Biotechnologies sc-135069, 1:100 dilution) proteins were used with anti-rabbit Alexa 
Fluor 488-IgG (Molecular Probes, Life Technologies A21206, 1:1000 dilution) as a 
secondary antibody.  Whole mount immunofluorescence was imaged with a Leica SP2 
scanning confocal microscope, using 40x and 63x objectives.  Z stacks were viewed as 
average or maximum projections. Section immunofluorescence was imaged with a 40x 
objective on a Nikon Eclipse TE2000-U inverted microscope. 
 
Luciferase Reporter Assay 
Six copies of the Ebox (CATCTG) located within the first exon -5bp from the Fap 
translational start site were PCR amplified and sublconed into the XhoI/Kpn1 sites of 
pGL3Promoter plasmid (Promega, Madison, WI).  The PARAXIS and E47 coding 
sequences were subcloned into the XhoI/XbaI sites of the CS2-HA plasmid to create the 
fusion proteins HA-PARAXIS and HA-E47. All clones were sequenced for verification. 
NIH3T3 mouse fibroblast cells were seeded at 4x104 cells/well in complete media 
[DMEM supplemented with 10% Newborn Calf Serum] in 24-well tissue-culture dishes.  
 25 
Each well was transfected with a total of 400 ng of plasmid DNA using 1 µl of 
Lipofectamine (Invitrogen, Carlsbad, CA) and 4 µl of PLUS reagent (Invitrogen, 
Carlsbad, CA), according to manufacture's protocol. Transfected cells were lysed 24 
hours post-transfection in 100 µl/well Luciferase Cell Culture Lysis Buffer (Promega, 
Madison, WI) and subjected to a single freeze-thaw cycle at -80oC.  Luciferase activity 
was measured for each well by reacting 20 µl of cell lysate with 100 µl of Luciferase Assay 
Buffer (Promega, Madison, WI) in white 96-well plates, using an FLx800 microplate 
reader (BioTek Instruments, Inc., Winooski, VT).  The experiment was performed in 
triplicate, and fold-change was calculated relative to luciferase activity levels derived 
from the 6xDmrt2 Ebox-pGL3P vector co-transfected with expression vectors encoding 
only the Ha peptide. 
 
Results And Discussion 
 The phenotype of the Paraxis-/- neonate, which results in lethality shortly after 
birth, is dominated by defects in the patterning of somite derivatives, suggesting that the 
primary role of PARAXIS is to maintain the spatial order of the compartments of the 
somite through the incipient epithelialization of the somites, and the maintenance of an 
epithelialized dermomyotome. Since PARAXIS activity is required for the induction of 
MET, identifying the genetic factors downstream of PARAXIS regulation in the newly 
formed somite and dermomyotome is a critical step in the characterization of the 
morphogenetic processes that occur during MET and EMT.   
 
ECM components Are Mislocalized in Paraxis-/- Somites 
The proper organization of the extracellular matrix components laminin and fibronectin 
is critical to the maintenance of an epithelial morphology in the somites (Danker et al., 
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1992; Girós et al., 2011; Koshida et al., 2005). To assess the degree of ECM organization 
surrounding cells in newly formed somites in E9.5 Paraxis-/- embryos, we examined the 
distribution of laminin using indirect immunofluorescence. An increased aggregation of 
laminin between adjacent somites is evident in wild type embryos (Figure 2A).  The 
equivalent region of the Paraxis-/- embryo stained positive for laminin in disorganized 
patches, but it did not display the same condensation at the intersomitic clefts (Figure 
2B). We also examined the distribution of fibronectin within the Paraxis-/- somite. In 
wild type somites, a fibronectin matrix surrounded the entire somite epithelium and was 
also concentrated within the mesenchymal somitocoel (Figure 2C). Fibronectin is less 
organized at the dorsal surface of Paraxis-/- somites and does not form continuous 
boundaries between somites in the mutant embryos (Figure 2D). Fibronectin normally 
condensed within the somitocoel was dispersed and was also observed to span somite 
boundaries in the absence of PARAXIS. These observations are consistent with a 
requirement for PARAXIS in the establishment of a proper ECM structure surrounding 
the somite during the initial stages of MET. 
 
Microarray Analysis of Somite MET in Paraxis-/- Mice Reveals Deregulated Genes 
Involved in Multiple MET Processes  
 To identify genes whose expression is impacted downstream of Paraxis during 
somite formation, we performed gene expression microarray analyses on pooled total 
RNA isolated from the anterior PSM and the four newest somites of E9.5 Paraxis-/- and 
Paraxis+/+ embryos.  This represents an embryonic time period when there is robust 
Paraxis expression in the anterior PSM and early somites. Tissue from five embryos with 
the same number of somites was pooled to create a sample, and three samples were 
collected for each genotype, as biological replicates. Genes displaying deregulation across  
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Figure 2. The ECM constituents laminin and fibronectin are mislocalized in the Paraxis-
/- embryo. Laminin protein labeled by indirect immunofluorescence in the posterior 
somites of E9.5 wild type (A) and Paraxis-/- embryos (B). Laminin is enriched at the 
intersomitic boundaries of wild type somites (arrowheads in A), but is lacking between 
Paraxis-/- somites (arrowheads in B). Indirect immunofluorescence in somite sections 
also reveals disorganized localization of fibronectin at the intersomitic boundaries of 
Paraxis-/- somites (white arrowheads in D), along the basal surface of the dorsal 
epithelium and in the region of the somitocoel, as compared to wild type embryos. 
Images display somites I-III, and are presented with anterior to the left and dorsal at the 
top. Image magnification is 400x.  
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all biological replicates were analyzed with Agilent Genespring GX software in order to 
identify those genes with expression level differences of at least 1.5-fold between 
Paraxis+/+ and Paraxis-/- embryonic tissue (Figure 3). 
 Our microarray analysis identified 795 genes whose expression was at least 1.5-fold 
up- or down-regulated in Paraxis-/- tissue, relative to wild type tissue.  PARAXIS is 
predicted to function as a transcriptional activator (Wilson-Rawls, 2004), and consistent 
with this, genes with the most significant changes in mRNA levels were downregulated in 
the absence of PARAXIS. However, this approach alone cannot distinguish between 
direct and indirect transcription regulation. Deregulated genes closely correlated (p < 
0.01) with a limited number of gene ontology (GO) term classifications associated with 
embryonic development processes, the extracellular matrix and the cell surface (Table 1), 
which is consistent with PARAXIS being required for the transcription of genes 
participating in cell-cell and cell-ECM adhesion. A more relaxed threshold (p<0.05) 
included GO terms associated with cell signaling pathways and transcription factor 
activity (Table 1), indicating that PARAXIS may control the transcription of MET-
associated genes through the activation of additional regulators. Based on either 
demonstrated or predicted function, we identified those genes that are associated with 
ECM organization, cytoskeleton organization, cell adhesion/repulsion, or cell 
signaling/transcription regulation from among the 795 deregulated genes (Tables 2 and 
3).  A change in expression level in the absence of PARAXIS was validated by qRT-PCR 
(Figure 5) for a select subset of these genes representing each table category, and for 
selected genes known to be expressed in the somites by whole-mount in situ 
hybridization (Figures 4 and 6). The diversity of the deregulated genes identified in our 
study suggests that PARAXIS is responsible for promoting several distinct morphological 
events associated with somite epithelialization. 
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Figure 3. Experimental design of our microarray-based gene expression analysis of 
Paraxis-/- embryos. Total RNA was extracted from PSM/early somite tissue samples from 
E9.5 wild type and Paraxis-/- embryos. RNA was pooled from 5 embryos for each of three 
biological replicates of each genotype, and used to create cRNA probes labeled with Cy3 
and Cy5 dyes. Probes were combined and hybridized to an Agilent two color gene 
expression microarray, and fluorescence intensities were measured to identify genes 
misexpressed in the Paraxis-/- embryo by at least 1.5-fold, relative to wild type samples. 
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Table 1. Microarray analysis reveals potential direct PARAXIS targets and 
associated Gene Ontology terms. 
GO Term # of genes P value 
Cellular development process 153 p<0.01 
Extracellular region 134 p<0.01 
Anatomical structure morphogenesis 112 p<0.01 
Regulation of cell communication 79 p<0.05 
Sequence-specific DNA binding transcription factor 
activity 
62 p<0.05 
Cell surface 45 p<0.01 
Embryonic morphogenesis 41 p<0.01 
Pattern specification process 39 p<0.05 
Skeletal system development 37 p<0.01 
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Table 2. Selected genes involved in MET/EMT, cell migration and/or cell 
adhesion that are upregulated at least 1.5-fold in Paraxis-/- vs Paraxis+/+ 
embryo PSM and somitic tissues. 
 
 Gene 
Symbol 
Fold 
Change 
Gene Name Accession 
No. 
Known or Inferred Function 
       Extracellular matrix organization 
 S100a
4 
2.8 S100 calcium binding 
protein A4 
NM_011311 Positive regulation of MMP 
expression, cell migration 
 A2m 2.5 alpha-2-macroglobulin NM_175628 Protease inhibitor 
 Olfml2
a 
2.0 olfactomedin-like 2A AK037205 Bind proteoglycans in the 
ECM* 
 Mmp9 1.9 matrix metallopeptidase 
9 
NM_01359
9 
Metalloendopeptidase 
activity 
 Clu 1.5 clusterin NM_01349
2 
MMP chaperone in ECM 
 Mfap5 1.5 microfibrillar associated 
protein 5 
NM_015776 Positive regulation of elastic 
fiber macroassembly 
       Cell adhesion / repulsion 
 Sdc4 4.1 syndecan 4 NM_011521 Positive regulation of focal 
adhesion assembly 
 Cldn11 2.3 claudin 11 NM_00877
0 
Tight junction assembly 
 Dsc2 1.7 desmocollin 2 NM_01350
5 
Desmosome assembly 
 Ctnna2 1.6 catenin, alpha 2 NM_00981
9 
Links adherens junctions to 
the cytoskeleton 
 Itga11 1.6 integrin alpha 11 NM_176922 Receptor for collagen 
 Nebl 1.6 nebulette NM_02875
7 
Positive regulation of focal 
adhesions 
       Cytoskeleton organization 
 Mid1 1.9 midline 1 AY540038 Negative regulation of 
microtubule 
depolymerization 
 S100a
6 
1.8 S100 calcium binding 
protein A6 (calcyclin) 
NM_011313 Interacts with tropomyosin 
to modulate actin dynamics* 
 Scin 1.7 scinderin NM_00913
2 
Actin filament capping and 
severing* 
 Krtap1
3 
1.7 keratin associated 
protein 13 
NM_010671 Intermediate filament 
structural protein* 
 Add2 1.7 adducin 2 (beta) NM_01345
8 
Actin-spectrin network 
assembly 
 Cobl 1.7 cordon-bleu NM_172496 Complexes with syndapin to 
regulate actin nucleation 
 Tmod1 1.6 tropomodulin 1 NM_02188
3 
Regulates actin filament 
lengths 
 Krt23 1.5 keratin 23 NM_03337
3 
Intermediate filament 
structural protein 
 Krtap2 1.5 keratin associated NM_001191 Intermediate filament 
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2-2 protein 22-2 018 structural protein * 
 Rhoh 1.5 ras homolog gene family, 
member H 
NM_00108
1105 
Negative regulation of actin 
filament assembly 
 Anxa8 1.5 annexin A8 NM_013473 Regulation of actin dynamics 
       Cell signaling / transcription regulation 
 Afap1l
2 
2.2 actin filament associated 
protein 1-like 2 
NM_146102 Positive regulation of EGFR 
signaling * 
 Lhx2 1.8 LIM homeobox protein 2 NM_010710 Transcription factor activity, 
mesoderm development 
 Cer1 1.8 cerberus 1  NM_00988
7 
BMP antagonist 
 Errfi1 1.7 ERBB receptor feedback 
inhibitor 1 
NM_133753 Inhibitor of EGFR signaling, 
 Arhgef
6 
1.6 Rac/Cdc42 guanine 
nucleotide exchange 
factor (GEF) 6 
NM_152801 Regulation of Rac1 signal 
transduction 
 Rasgrf
1 
1.5 RAS protein-specific 
guanine nucleotide-
releasing factor 1 
NM_00103
9655 
Negative regulation of Cdc42 
activation 
            * Function inferred from sequence orthology or indirect assay. 
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Table 3. Selected genes involved in MET/EMT, cell migration and/or cell 
adhesion that are downregulated at least 1.5-fold in Paraxis-/- vs Paraxis+/+ 
embryo PSM and somitic tissues. 
 
 Gene 
Symbol 
Fold 
Change 
Gene Name Accession 
No. 
Known or Inferred Function 
       Extracellular matrix organization  
 Fap 16.2 fibroblast activation protein NM_00798
6 
Serine protease, regulation of 
EMT/MET 
 Itih5 3.7 inter-alpha (globulin) 
inhibitor H5 
NM_172471 Serine-type endopeptidase 
inhibitor activity* 
 Abi3bp 3.0 ABI gene family, member 3 
(NESH) binding protein 
NM_00101
4423 
Collagen binding, positive 
regulation of cell-substrate 
adhesion 
 Plod1 1.9 procollagen-lysine, 2-
oxoglutarate 5-dioxygenase 1 
NM_011122 Collagen assembly 
 Pcolce 1.7 procollagen C-endopeptidase 
enhancer protein 
NM_00878
8 
Stimulation of procollagen 
processing 
       Cell adhesion / repulsion 
 Adam1
8 
11.0 a disintegrin and 
metallopeptidase domain 18 
NM_01008
4 
Metalloprotease / disintegin 
activity * 
 Adamts
l3 
2.2 ADAMTS-like 3 NM_00119
0374 
Regulation of cell-ECM 
interaction, assembly of ECM 
 Wisp2 2.1 WNT1 inducible signaling 
pathway protein 2 
NM_01687
3 
Inhibition of fibrinogen-
integrin binding 
 Epha7 2.0 Eph receptor A7 NM_001122
889 
Eph-ephrin bi-directional 
signaling 
 Lin7a 1.9 lin-7 homolog A  NM_00103
9354 
Regulation of tight junction 
assembly 
 Vcam1 1.9 vascular cell adhesion 
molecule 1 
NM_011693 Interacts with α4β1 integrins 
to mediate cell-cell adhesion 
 Ntn1 1.8 netrin 1 NM_00874
4 
Binds receptor to mediate 
cell-cell and cell-ECM 
interactions 
 Lnx1 1.8 ligand of numb-protein X 1 BC040367 Facilitates the redistribution 
of JAM4 to newly forming 
tight junctions 
 Nlgn1 1.8 neuroligin 1 AK083116 Forms intercellular junctions 
by binding beta-neurexins 
 Pcdhga
12 
1.7 protocadherin gamma 
subfamily A, 12 
BC066851 Mediates calcium-dependent 
cell-cell adhesion* 
 Pcdhb1
6 
1.6 protocadherin beta 16 NM_053141 Mediates calcium-dependent 
cell-cell adhesion* 
 Ntm 1.6 neurotrimin AK018085 Cell adhesion molecule* 
 Epha3 1.6 Eph receptor A3 NM_01014
0 
Eph-ephrin bi-directional 
signaling 
 Sdk2 1.6 Sidekick homolog 2 AK052040 Transmembrane protein 
mediating homophilic cell 
adhesion 
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 Tgfb3 1.6 transforming growth factor, 
beta 3 
NM_00936
8 
Activates repressors of 
cadherin-based adhesion, 
initiates EMT 
 Itgav 1.5 integrin alpha V AK080357 Heterodimeric receptor for 
ECM-mediated focal adhesion 
assembly 
 Frmd4
a 
1.5 FERM domain containing 
4A 
AK029073 Scaffolding protein mediating 
Arf6 activation at adherens 
junctions 
 Utrn  1.5 utrophin NM_011682 Member of a complex which 
links the cytoskeleton to the 
ECM  
       Cytoskeleton organization 
 Dnm3 5.4 dynamin 3 NM_00103
8619 
Microtubule bundle 
assembly, vesicle endocytosis 
 Krt79 2.0 keratin 79 NM_14606
3 
Intermediate filament 
structural protein * 
 Daam2 2.0 dishevelled associated 
activator of morphogenesis 2 
NM_00100
8231 
Regulation of cell polarity, 
binds Rho GTPase and 
cytoskeleton 
 Cttnbp
2 
1.8 cortactin binding protein 2 NM_08028
5 
Regulation of cortactin-
dependent actin dynamics 
 Numa1 1.8 nuclear mitotic apparatus 
protein 1 
NM_133947 Positive regulation of 
microtubule assembly 
 Mapre1 1.7 microtubule-associated 
protein, RP/EB family, 
member 1 
NM_00789
6 
Positive regulation of 
microtubule assembly 
 Dst 1.6 dystonin NM_13444
8 
Integration of cytoskeletal 
elements 
 Dock2 1.6 dedicator of cyto-kinesis 2 NM_03337
4 
Regulation of actin 
polymerization, Rac GTPase 
activator activity 
 Nav1 1.6 neuron navigator 1 NM_173437 Positive regulation of 
microtubule assembly 
 Cald1 1.6 caldesmon 1 NM_145575 Stabilization of actin 
filaments 
 Pard3 1.6 par-3 (partitioning defective 
3) homolog (C. elegans) 
NM_03362
0 
Regulation of cell polarity, 
formation of tight junctions 
 Zfp185 1.6 zinc finger protein 185 NM_00954
9 
Modulation of actin filament 
dynamics * 
 Akap2 1.5 A kinase (PRKA) anchor 
protein 2 
NM_00103
5533 
Modulation of actin filament 
dynamics* 
 Capn6 1.5 calpain 6 AK048028 Positive regulation of 
microtubule stability, 
modulation of Rac GTPase  
       Cell signaling / transcription regulation 
 Meox2 3.1 Mesenchyme homeobox 2 NM_00858
4 
Transcription factor activity, 
mesoderm specification 
 Dmrt2 3.0 doublesex and mab-3 related NM_145831 Transcription factor activity 
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transcription factor 2 
 Heyl 2.3 hairy/enhancer-of-split 
related with YRPW motif-
like 
NM_01390
5 
Transcription factor activity, 
Notch signaling 
 Wnt2 2.0 wingless-related MMTV 
integration site 2 
NM_02365
3 
Binds frizzled receptor and 
induces EMT by activating β-
catenin 
 Twist1 1.7 twist homolog 1  NM_011658 Transcription factor activity, 
positive regulation of EMT 
 Twist2 1.7 twist homolog 2  NM_00785
5 
Transcription factor activity 
 Onecut
1 
1.6 one cut domain, family 
member 1 
NM_00826
2 
Transcription factor activity, 
regulation of cell-matrix 
adhesion 
 Ets1 1.6 E26 avian leukemia 
oncogene 1, 5' domain 
NM_01180
8 
Transcription factor activity, 
cell migration, activates 
MMPs 
 Rnd2 1.6 Rho family GTPase 2 NM_00970
8 
GTPase mediated signal 
transduction, modulation of 
cell migration 
 Met 1.6 met proto-oncogene NM_00859
1 
Positive regulation of EMT 
 Tead1 1.5 TEA domain family member 
1 
NM_00934
6 
Transcription factor activity, 
paraxial mesoderm 
specification 
            * Function inferred from sequence orthology or indirect assay. 
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PARAXIS Regulates Genes Associated with Extracellular Matrix Stabilization and 
Remodeling 
 The most striking changes in gene expression in Paraxis-/- somites and PSM were 
found among cell surface proteins that modify ECM organization (Tables 2 and 3). Many 
of these genes were not previously predicted to participate in somite MET. Notable 
among these was fibroblast activation protein alpha (Fap) (16.2-fold down-regulated; 
Table 3), a gene encoding a transmembrane protein that possesses dipeptidyl peptidase 
and gelatinase/collagenase activities, and that increases the level of fibronectin and 
collagen fiber organization in ECM (Aertgeerts, 2005; Lee et al., 2011; Levy et al., 1999). 
FAP, through association with integrins and urokinase plasminogen activator receptor 
(UPAR) within focal adhesions, regulates the integrin-dependent cell migration of tumor 
cells (Artym, 2002; Lee et al., 2011; Mueller, 1999). We confirmed that Fap transcripts 
are reduced in Paraxis-/- somites by qRT-PCR (Figure 5B) and in situ hybridization 
(Figure 4A & B).  In E9.5 wild type mouse embryos, FAP was localized to both the apical 
and basal cell surfaces of the epithelial cells in the somite (Figure 4C), suggesting that 
FAP is important for the interaction of the epithelium with the ECM, perhaps controlling 
the establishment and maintenance of the separation of the epithelium from its 
surrounding tissues. Consistent with this, the organization of the fibronectin matrix 
surrounding Paraxis-/- somites is disturbed (Figure 2). Given the dramatic 
downregulation of Fap in Paraxis-/- somites, we examined whether Fap was a direct 
target of PARAXIS. When forming a dimer with E47, PARAXIS was able to modestly 
activate transcription from a highly conserved Ebox located within the Fap promoter. 
These results suggest that PARAXIS can directly activate Fap in newly forming somites, 
and that this activation is essential for proper somite ECM organization.  
 Among the genes that were upregulated in the absence of Paraxis were those that  
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Figure 4. Expression of Fibroblast Activating Protein in the Somite Epithelium is 
localized to the apical and basal epithelial surfaces, and is activated by PARAXIS. Whole-
mount in situ hybridization for Fap in E9.5 wild type (A) and Paraxis-/- (B) somites and 
PSM reveals strong downregulation in the absence of Paraxis. (C) The distribution of 
FAP in somite IV of the E9.5 wild type embryo was visualized by indirect 
immunofluorescence using an antibody specific for FAP-α.  FAP was localized to both the 
apical and basal aspects of the somite epithelium. Luciferase-based reporter assays (D) 
demonstrate that PARAXIS, in combination with E47, is able to activate transcription 
more than 3.5-fold from a multimerized Ebox found within the first exon of Fap. Somite 
images are presented with anterior to the left and dorsal at the top, and image 
magnification in C is 200x. 
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Figure 5. Genes involved in MET processes are deregulated in the Paraxis-/- PSM and 
somite tissue.  Relative gene expression, as measured by qRT-PCR, of selected 
upregulated (A) and downregulated (B) genes known to be involved in ECM 
organization, cell-cell and cell-ECM adhesion, cytoskeletal rearrangements and MET-
related cell signaling and transcriptional regulation. QRT-PCR was performed in 
triplicate, with duplicate samples for each genotype. Error bars represent +/- one 
standard deviation. Expression level differences for each gene shown were analyzed 
using a non-parametric Mann-Whitney test, and found to be statistically significant at a 
p-value of 0.05. 
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Figure 6. PARAXIS positively regulates the expression of genes that are involved in MET. 
In situ hybridization of selected downregulated MET genes in wild type and Paraxis -/- 
E9.5 embryos. Expression levels of EphA7, EphA3, Adam18, Dmrt2, Daam2, Twist1, 
Heyl, Meox2, Dnm3os and Dock2 were either dramatically reduced, or entirely lost, in 
the posterior somites and presomitic mesoderm of Paraxis -/- embryos. Faint expression 
of EphA7, Daam2 and Dock2 remained in the anterior somites, and a weak stripe of 
EphA3, Dmrt2, Heyl, and Meox2 expression persisted in the presomitic mesoderm of 
mutant embryos. Expression domains and intensities of these genes outside of the 
paraxial mesoderm were unaffected. 
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promote cell migration through ECM breakdown.  Included in these were S100a4, 
encoding an EF-hand calcium-binding protein associated with metastatic tumors 
(reviewed in Helfman et al., 2005; Schneider et al., 2008) and the matrix 
metalloproteinase, MMP9 (Table 2, Figure 5A).  Interestingly, S100A4-dependent 
invasion of tumor cells is dependent on promoting MMP transcription and activity, 
including MMP9 (Saleem et al., 2006; Schmidt-Hansen, 2004). The metalloproteinase 
activity of MMP9 promotes EMT in renal tubular cells (Tan et al., 2010). It is possible 
that PARAXIS represses the same pathway in the paraxial mesoderm in order to 
abrogate the destruction of the ECM necessary to support the establishment of an 
epithelium.  
 
PARAXIS Regulates Genes Encoding Cell-ECM and Cell-Cell Adhesion Proteins  
 Based on the importance of cell-ECM and cell-cell interactions in MET, genes 
associated with these processes were examined in the Paraxis-/- embryos.  Genes 
associated with both interactions were found to be deregulated in the absence of 
PARAXIS (Table 2 & 3).  Notable among them was Itgav, encoding an integrin that, 
along with ITGA5, binds to fibronectin and is essential for the formation of focal 
adhesions in somites (Yang et al., 1999). It has been previously shown that blocking focal 
adhesion formation does not inhibit Paraxis transcription, suggesting that PARAXIS 
activity occurs upstream of focal adhesion assembly (Rifes et al., 2007).  Interestingly, 
syndecan 4 (Sdc4), encoding an integrin co-receptor, was upregulated 4.1-fold (Table 2; 
Figure 5A).  The impact of the increase in Sdc4 on somite morphology in the Paraxis-/- 
embryo is not clear.  However, it is possible that this change may cause a disruption of 
focal adhesions through a stoichiometric imbalance.  
 The Eph-ephrin bidirectional signaling pathway regulates the reorganization of the 
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cytoskeleton that can direct either cell-cell adhesion or repulsion (reviewed in Noren and 
Pasquale, 2004; Poliakov et al., 2004). EphA3 and EphA7 receptors were downregulated 
1.6- and 2.0-fold, respectively (Table 3). Downregulation of EphA7 was confirmed by 
qRT-PCR (Figure 5B), and in situ hybridization for both genes in the Paraxis-/- embryo 
(Figure 6). Previously, EPHA3 activity was shown to be required for somite boundary 
formation in Zebrafish, while EPHA7 was associated with neural crest cell migration 
(Araujo and Nieto, 1997; Araujo et al.; Lackmann, 1998). This raises the possibility that 
EPHA3 and EPHA7 are required for adhesive processes during the epithelialization of 
the somites.  EphA7 is subsequently expressed in the dermomyotome (Araujo and Nieto, 
1997), which maintains the epithelialization established during somitogenesis, 
supporting the idea that this receptor may be required to establish and maintain highly 
adhesive tissues.   
 Members of the A Disintegrin and Metalloprotease (ADAM) family, Adam18 and 
Adamtsl3 were downregulated significantly in Paraxis-/- embryo PSM and somites 
(Table 3). The membrane-bound proteins encoded by these genes can participate directly 
in cell adhesion or inhibit adhesion through ectodomain shedding of type I or type II 
transmembrane proteins (Weber and Saftig, 2012). ADAM18 is a cell surface protein 
present on sperm membranes, where it is predicted to increase cell adhesion through 
interactions with egg integrins (Frayne, 2002; Weber and Saftig, 2012). By in situ 
hybridization, we confirmed that Adam18 is transcribed in somites and is downregulated 
in the absence of PARAXIS (Figure 6), raising the possibility that it promotes MET 
through a PARAXIS-dependent mechanism.  
 
PARAXIS Regulates Cytoskeleton Reorganization During MET  
 MET is associated with a reorganization of the cytoskeleton that affects cell 
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morphology, promotes apical/basal polarity, and provides structural support for cell 
adhesion.  Members of the Rho GTPase family (RHOA, RAC1, CDC42) integrate signals 
from adhesion molecules to direct distinct morphological outcomes that help to stabilize 
the epithelium (reviewed in Hall, 2005). All three of these GTPases are known to be 
involved in the regulation of cytoskeletal dynamics during somitogenesis (Nakaya et al., 
2004; Takahashi et al., 2005; Watanabe et al., 2007). While actin filaments and RHOA 
protein are not properly localized in Paraxis-/- somites (Rowton et al., 2013), the mRNA 
levels of RhoA, Rac1 and Cdc42 themselves were not altered by at least 1.5-fold by 
microarray. Instead, modifiers of Rac1 and Cdc42 GTPase activity were altered (Tables 2 
& 3). The guanine nucleotide exchange factor (GEF), Dock2 (Fukui et al., 2001), was 
downregulated 1.6-fold, which was confirmed by in situ hybridization in E9.5 Paraxis-/- 
embryos (Figure 6).  The Rac1-specific GEF, Arhgef6 was upregulated in Paraxis-/- 
tissue, 1.6-fold (Table 2, Figure 5A). Further, Capn6 (1.5-fold down, Table 3), coding for 
a microtubule-stabilizing protein, is expressed in the somites of mouse embryos (Dear 
and Boehm, 1999) and can promote RAC1 activity by binding ARHGEF2 (Tonami et al.). 
The deregulation of genes encoding modifiers of RAC1 activity predicts that regulation of 
Rho GTPase activity by PARAXIS occurs indirectly during somitogenesis.  
 
PARAXIS Controls Developmental Regulatory Genes Associated with Somitogenesis  
 Activation of the canonical Wnt signaling pathway has been implicated in both 
segmentation and MET during somitogenesis.  WNT6, acting through a β-CATENIN-
dependent pathway, is required to maintain Paraxis transcription and somite MET in 
the chick embryo (Linker, 2005). In our microarray analysis of Paraxis-/- somites, the 
transcription of components of the canonical Wnt signaling pathway, including Wnt2, 
Wisp2, and Daam2, were downregulated (Table 3). The transcript level reduction of 
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Daam2, the product of which stabilizes the DVL3/AXIN2 complex and modulates the 
activity of Rho GTPases (Lee and Deneen, 2012), was confirmed by both qRT-PCR and in 
situ hybridization (Figure 5B and 6).  Dvl3 is also expressed in the somites of mouse 
embryos (Tsang et al., 1996) and is required for normal somite formation in zebrafish 
embryos (Gray et al., 2009). These findings reveal a potential positive feedback loop 
between PARAXIS and Wnt signaling, as well as a possible mechanism by which 
PARAXIS may regulate Rho GTPases.  
 Several transcription factors associated with specification and differentiation of 
paraxial mesoderm are downregulated in the absence of PARAXIS.  Of particular interest 
was Dmrt2, as the somites of Dmrt2-/- mutants fail to epithelialize, a phenotype similar 
to Paraxis-/- embryos (Burgess et al., 1996; Seo et al., 2006). Dmrt2 was downregulated 
3.0-fold by microarray analysis and almost 60% by qRT-PCR (Table 3, Figure 5B).  
Based on in situ hybridization, this reduction was specific to the somites (Figure 6). It 
has been proposed that DMRT2 controls somite MET through induction of laminin 
expression (Seo et al., 2006). The downregulation of Dmrt2 is therefore consistent with 
the reduced and diffuse expression of laminin observed in Paraxis-/- embryos (Figure 2). 
These observations predict that PARAXIS modulates the localization of laminin and 
other ECM proteins required for epithelialization through the activation of Dmrt2 in the 
newly forming somites.  Alternatively, the disruption of laminin may be linked to the 
disruption of fibronectin, which we also observed in Paraxis-/- somites (Figure 2). 
 Additional transcription factors that require PARAXIS for proper somite 
expression include, MEOX2, TWIST1, TWIST2, and HEYL (Table 3).  MEOX2, which 
regulates somite epithelialization and directs Paraxis transcription in combination with 
MEOX1 (Mankoo, 2003), was downregulated 3.1-fold (Figures 5B & 6). This finding is 
supported by a recent report that demonstrates that Paraxis cooperates with Mef2d to 
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direct transcription of meox2 in the Xenopus PSM (Gaspera et al., 2012).  Together, 
these observations indicate that there is a positive feedback loop between MEOX2 and 
PARAXIS during somitogenesis. Further, PARAXIS is required for proper transcription 
of Twist1 and Twist2 (Table 3), which share strong homology with PARAXIS in their 
bHLH domains. TWIST1 is essential for specification of paraxial mesoderm and 
positively regulates the transcription of Fap (Mikheeva et al., 2010), Dynamin3 (Dnm3), 
and Dnm3os (Loebel et al., 2005), genes that are also downregulated in our studies 
(Table 3, Figure 6).  Heyl, a downstream target of Notch signaling, was also found to be 
downregulated (2.3-fold) in Paraxis-/- somites (Table 3). Heyl is dynamically expressed 
in the presomitic mesoderm as a component of the segmentation clock (Leimeister et al., 
2000; Nakagawa et al., 1999), in addition to being statically expressed in the posterior 
aspect of somites (Figure 6).  HeyL expression was undetectable in the somites of 
Paraxis-/- embryos, and strongly downregulated in the anterior PSM (Figure 6). In 
addition to Meox2, Twist1, Twist2 and HeyL, genes encoding additional transcription 
factors, such as Pax1 (36.0-fold downregulated, data not shown), were deregulated in the 
absence of PARAXIS, indicating that PARAXIS is involved not only in the regulation of 
various MET processes, but also in cell fate decisions within the paraxial mesoderm.   
 Our transcriptional analysis of the somites and PSM of Paraxis-/- embryos has 
provided unique insight into the functional role of PARAXIS in somite MET.  Instead of 
participating in a linear regulatory path that promotes the transcription of structural 
genes necessary for the initiation of an epithelial cell morphology, PARAXIS appears to 
participate in a more complex regulatory network that acts at the basal surface of the 
epithelium, through the stabilization of the ECM and regulation of the transcription of 
genes required for cell-ECM adhesion, and through the organization of cytoskeletal 
elements by differential modulation of Rho GTPase activity.  Previous studies have 
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demonstrated the importance of ECM composition and adhesion proteins at focal 
adhesions for proper somitogenesis (George et al., 1993; Jülich et al., 2005; Mostafavi-
Pour et al., 2003; Rifes and Thorsteinsdóttir, 2012; Rifes et al., 2007; Wehrle-Haller, 
2012; Woods and Couchman, 2001; Yang et al., 1999; Yang et al., 1993). These studies, 
combined with our expression analyses, suggest that PARAXIS serves as a regulatory 
node for integrating intra- and extracellular cellular events that are temporally 
connected during somite MET.  Further, this study has identified additional genes that 
are expressed in the mouse somite and may serve as critical regulators during 
somitogenesis. Significant among these are Fap, Adam18, and EphA7, encoding proteins 
that are predicted to participate in ECM reorganization, focal adhesions, and cell 
migration in other tissues in the embryo (Frayne, 2002; Lee et al., 2011; Mueller, 1999; 
Niedermeyer et al., 2001; Weber and Saftig, 2012). 
 Finally, one of the more striking findings of our analysis was the role of PARAXIS 
in promoting the expression of key developmental regulatory genes.  The Wnt and Notch 
pathways are both critical for patterning, MET, and tissue differentiation during 
somitogenesis.  Through induction of Daam2 and Heyl transcription, PARAXIS can 
modify the signaling activity of these pathways.  Further, MEOX2 and DMRT2 are 
transcription factors that have been implicated in somite MET based on deletion studies 
in mouse embryos (Mankoo, 2003; Seo et al., 2006).  This makes both genes likely 
proximate targets of a PARAXIS-directed regulatory cascade.  In support of this, 
Xenopus PARAXIS and MEF2C are able to directly activate the Meox2 promoter 
(Gaspera et al., 2012). Future studies will be required to determine if Meox2 and other 
PARAXIS-dependent genes are direct targets of PARAXIS in mouse somite MET.   
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Chapter 3 
PARAXIS controls epaxial and hypaxial myogenesis through PAX3-dependent pathways 
 
Introduction 
In many vertebrates, including mammals and birds, skeletal muscle is derived 
from myogenic progenitor cells (MPCs) embedded in the epithelial dermomyotome 
compartment of individual somites.  The first evidence of cells specified to the myogenic 
lineage is associated with their delamination from the dorso-medial lip (DML) of the 
dermomyotome and subjacent migration to the interface with the sclerotome.  As 
described in Chapter 1, the subsequent growth and organization of the resulting 
myotome compartment is inextricably linked to the dermomyotome through waves of 
cell migration, and because the epithelium serves as a scaffold for myocyte elongation.  
At the limb level, a unique migratory population of MPC’s delaminate from the ventro-
lateral lip (VLL) of the dermomyotome to form the premuscle masses of the 
appendicular and limb girdle muscles (reviewed in Brand-Saberi et al., 1996b; Brent, 
2002; Christ and Ordahl, 1995). The spatio-temporal regulation of the morphogenesis of 
the myotome from the dermomyotome is well-studied (Buckingham, 2006; Buckingham 
et al., 2003; Molkentin and Olson, 1996; Olson and Klein, 1994). However, the factors 
controlling myotome patterning, and the subsequent migration of the subset of 
dermomyotomal cells fated to the myogenic lineage into the limbs, is not as well 
understood.  
The epithelial state of the dermomyotome is initially regulated by Wnt signaling 
directed from the surface ectoderm. WNT6, acting through the canonical Wnt pathway 
protein, β-CATENIN, maintains dermomyotome epithelialization.  WNT-6 and β-
CATENIN stimulate Paraxis transcription, predicting a mechanism by which the Wnt 
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pathway directs epithelialization.  This is supported by the observation that 
overexpression of Paraxis will rescue the epithelial phenotype of the dermomyotome in 
the absence of WNT6 (Linker, 2005).  WNT11, collaborates with WNT6 to maintain the 
DML and VLL of the dermomyotome, containing the MPC in an epithelial state (Geetha-
Loganathan, 2006). WNT11 is also required for the proper orientation of myoblast 
elongation in the myotome, suggesting a link between the epithelial state of the 
dermomyotome and myotome organization (Gros et al., 2008).  This is most likely 
mediated by the extracellular matrix produced along the apical surface of the 
dermomyotome epithelium and between the myotome and sclerotome. Candidates for 
mediating this interaction are the integrins expressed on the surface of MYF5+ve 
myoblasts, which bind fibronectin or laminin. Cells in the region of the DML and the 
adjacent myotome express α6β1 integrin, which binds laminin in the ECM and organizes 
it into a basal lamina (Bajanca, 2006).  In the medial and ventral region of the myotome, 
the expression shifts to α4β1 integrin, which binds fibronectin, suggesting a change in 
affinity (Bajanca et al., 2004).  
 A second, migratory population of MPCs are derived from the VLL of epithelial 
dermomyotome (Bothe et al., 2007; Buckingham, 2006; Evans et al., 2006). In the 
anterior somites that express Tbx3, the migratory cells coalesce to form the hypoglossal 
chord, which gives rise to integral muscles of the neck and the diaphragm (Huang et al., 
1999).  At the levels of the forelimb and hindlimb buds MPCs express Met and Lbx1 and 
migrate laterally into the limb bud mesenchyme (Buckingham et al., 2003). A role for 
PARAXIS has been predicted in the cells of the VLL. A delay in hypaxial trunk 
myogenesis is evident in the absence of Paraxis, as well as a delay in MPC migration into 
the limb (Wilson-Rawls et al., 1999). This delay is associated with a lack of expression of 
the differentiation marker, MyoD, in the hypaxial dermomyotome. It has been 
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hypothesized that compensatory MYF5+ve epaxial myocytes rescue the deficit in myoblast 
specification and migration after approximately 2 days. Supporting this, Myf5/Paraxis 
double knockout mutants are born missing several epaxial and hypaxial muscles, and 
display severe hypoplasia of the limb muscles (Wilson-Rawls et al., 1999) 
 The transcription factor, PAX3, is predicted to play a central role in regulatory 
networks that control specification, epithelial morphology and migratory behavior of 
MPCs (Figure 1). Pax3 is expressed throughout the dermomyotome as it forms, before 
becoming restricted to the persistently epithelial DML and VLL (Williams and Ordahl, 
1994). Pax3 expression, is dependent upon the combinatorial activity of the homeobox 
transcription factors, MEOX1 and 2 (Mankoo, 2003).  
During the initial formation of the epaxial myotome, PAX3 directly regulates the 
expression of Dmrt2 (Sato et al., 2010), which itself controls laminin production in the 
myotome (Seo et al., 2006). Embryos lacking Dmrt2 do not form a basement membrane 
separating the myotome from the sclerotome. This could be due either to a lack of 
laminin production, or to a lack of integrin α6β1 activation (Sato et al., 2010).  
PAX3-mediated delamination of MPCs from the VLL is dependent on the 
coordinated action of members of the of SIX and EYA transcription factor families 
(Figure 1) (Tajbakhsh et al., 1997; Grifone et al., 2007; Grifone et al., 2005). PAX3 
activates the expression of the tyrosine kinase receptor MET in MPCs while they are still 
in the dermomyotome, rendering them competent to delaminate and migrate into the 
limb in the presence of its ligand, Hepatocyte Growth Factor, also known as scatter 
factor (HGF/SF), (Brand-Saberi et al., 1996a; Dietrich et al., 1999; Epstein et al., 1996). 
MPCs fail to migrate into the limb in embryos with mutations in Pax3, Met or HGF 
(Bladt et al., 1995; Schmidt et al., 1995; Tajbakhsh et al., 1997). After MPCs have 
delaminated, they migrate towards the dorsal and ventral aspect of the limb bud, where 
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Figure 1. PAX3 regulates epaxial and hypaxial myogenesis. A schematic highlighting 
PAX3-dependent pathways important for myotome basement membrane formation 
(purple circle) and limb MPC migration (blue circle). Solid arrows denote direct 
interactions, while dashed arrows denote interactions for which there is no evidence for 
direct activation. 
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they will form the extensor and flexor muscles of the arm and leg (Buckingham et al., 
2003). Migrating cells express the ladybird homeobox transcription factor LBX1, which 
is essential for MPC migration into the limb, and is also targeted by PAX3 transcriptional 
regulation (Brohmann et al., 2000; Gross et al., 2000; Mennerich et al., 1998; Schafer 
and Braun, 1999). LBX1+ve cells also express α5β1 and α1β1 integrins, receptors for 
fibronectin and laminin, respectively (Bajanca and Thorsteinsdóttir, 2002). Both 
fibronectin and laminin are present in the limb bud during MPC migration (Godfrey and 
Gradall, 1998; Kosher et al., 1982), and MPCs fail to migrate into the limb when they are 
inhibited from binding fibronectin (Brand-Saberi et al., 1993b). The results of these 
studies demonstrate that receptor-ligand interactions are critical to the migration of 
MPCs into the limb, and that the genetic cascade that controls the expression of these 
cell-surface receptors are directed by PAX3. 
Proliferate and differentiate of MPCs in the limb is dependent on the expression 
of PAX3, MYF5, MEOX2, and NOTCH (Delfini et al., 2000; Mankoo et al., 1999).  
Activation of the Notch pathway in myoblasts leads to the stabilization of Myf5 
expression and a downregulation of the differentiation marker MyoD (Delfini et al., 
2000). Myf5 expression in the limb is also dependent upon MEOX2, and in the absence 
of Meox2, mouse neonatal limb muscle mass is greatly reduced and several forelimb 
muscles are absent (Mankoo et al., 1999). The initiation of MyoD expression in the limb 
marks the point at which MPCs stop proliferating and enter into a differentiation 
program (Kablar et al., 1999). Mouse embryos lacking MyoD exhibit a 2.5-day delay in 
limb myogenesis, while Pax3 and Myf5 are normally expressed in these embryos, 
suggesting that it is MyoD, and not genes upstream of it, that is required for the 
temporal regulation of limb muscle differentiation (Kablar et al., 1997). MyoD 
expression is activated by EYA2 and SIX1, which are expressed in the limb bud at this 
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time, in addition to regulating Pax3 expression in the VLL (Heanue et al., 1999). 
Differentiating limb myoblasts then fuse to form myotubes, while expressing the 
terminal differentiation markers Myogenin and Mef2 (Edmondson et al., 1994; Sassoon 
et al., 1989). Finally, tendon precursors migrating from the syndetome express Scleraxis 
and Mkx, and migrate between the developing muscle masses and condensing cartilage 
to connect the components of the appendicular musculoskeletal system (Anderson et al., 
2006; Schweitzer et al., 2001).  
Paraxis-/- embryos display a dramatic downregulation of Pax3 in the 
dermomyotome and the limb buds (Wilson-Rawls et al., 1999), suggesting that the delay 
in myogenesis observed in Paraxis-/- embryos is due to the deregulation of the epaxial 
and hypaxial PAX3-dependent pathways. The mechanism by which PARAXIS modulates 
these pathways has not yet been identified. While we know that the differentiation 
marker, MyoD, fails to be properly expressed in the absence of PARAXIS, it is unclear 
whether this is due to a direct regulation of myogenic differentiation by PARAXIS,. 
Migratory MPCs in the Paraxis-/- somite do not have an epithelial dermomyotome from 
which to delaminate, raising the possibility that a lack of EMT could lead to aberrant 
migration or differentiation of these cells. The migration pattern of MPCs and the cell-
ECM interactions necessary for migration also have not been characterized in the 
absence of Paraxis. Finally, the proliferation of MPCs in the limb bud prior to 
differentiation could be affected by a lack of Paraxis, leading to the expression of 
differentiation markers by very few myoblasts in the limb. 
Here, we examine the role of PARAXIS in epaxial and hypaxial myogenesis. 
Using immunofluorescence, qPCR and in situ hybridization, we examine the expression 
levels and distributions of proteins involved in the organization of the early myotome. 
We find that the basal lamina in Paraxis-/- myotomes is not properly formed, leading to 
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the mislocalization and misalignment of myotomal myocytes. We also demonstrate 
various defects in neonatal appendicular musculature in the absence of Paraxis. We 
evaluate the potential causes of these defects in the developing embryo, and conclude 
that the deficits originate from a failure of MPC delamination from a mesenchymal 
dermomyotome and a lack of MPC migration into the limb. Finally, we demonstrate both 
direct and indirect regulation of Pax3 expression by PARAXIS, and we conclude that 
PARAXIS engages PAX3-dependent pathways to affect the ability of MPCs to interact 
with their environment. 
 
Materials and Methods 
Animals 
Mice carrying a null allele for the gene Paraxis (Burgess et al., 1996) were 
maintained as heterozygotes (Paraxis+/-) according to Institutional Animal Care and Use 
Committee guidelines. Embryos were genotyped by duplex PCR on embryo yolk sacs 
using the primers ParaxisWTF: GTCTGGCGTCCAGCTACATC, ParaxisNeoF: 
TGCTCCTGCCGAGAAAGTAT, ParaxisWT/NeoR: GAGCATCAGGCAAGAGGAAG. For β-
galactosidase staining, Paraxis+/- mice were crossed to mice carrying the transgene -
1565Myogenin-LacZ (Cheng et al., 1992). 
 
β-galactosidase staining 
E9.5 or E12.5 wild type and Paraxis-/- embryos that carried the -1565Myogenin-
LacZ transgene were harvested and fixed in 4% PFA/0.2% Glutaraldehyde in PBS for 30 
minutes (E10.5) or 1 hour (E12.5) at room temperature. Embryos were then rinsed in 1x 
PBS 3 times for 5 minutes, and stained in a solution of 50mM K-Ferrocyanide/50mM K-
Ferricyanide/1M MgCl2/20mg/ml X-Gal (Fermentas, #R0401) in PBS overnight with 
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rotation at room temperature. Embryos were rinsed 3 times for 10 minutes in PBS and 
fixed in 4% PFA overnight at 4°C. Embryos were photographed using a SMZ1000 
stereodissecting microscope (Nikon) with a Retiga CCD digital camera (Q-Imaging). 
Fixed embryos were embedded, frozen and sectioned as described previously (Anderson 
et al., 2006), except that 10uM sections were collected. Sections were imaged using 4x 
and 40x objectives on a Nikon Eclipse TE2000-U inverted microscope. β-galactosidase+ve 
myocytes from 3 sections each for 3 wild type and 3 Paraxis-/- samples were counted 
using ImageJ (Schneider et al., 2012), and cell counts were compared using a Student’s 
T-test with p ≤ 0.05. 
 
Immunofluorescence 
E10.5 wild type and Paraxis-/- embryos were fixed in 4% PFA at 4°C overnight. 
For whole mount immunofluorescence, embryos were permeabilized in 0.1% Triton-X in 
PBS (PBS-T) at 4°C for overnight with rotation. Embryos were then blocked in 1%BSA in 
PBS 2 times for 1 hour and incubated with primary antibody in 0.1%BSA for 3 days at 
4°C. Embryos were then rinsed in PBS 5 times for 1 hour and incubated with secondary 
antibody in 0.1%BSA for 2 days at 4°C. Whole mount immunofluorescence was imaged 
with a Leica SP2 scanning confocal microscope, using 40x and 63x objectives.  Z stacks 
were viewed as average or maximum projections. 
For section immunofluorescence, embryos were embedded, frozen and sectioned 
as described above for β-galactosidase staining. Sections were permeabilized in 0.1% 
PBS-T for 20 minutes at room temperature. Antigen retrieval was performed in boiling 
10mM sodium citrate buffer, pH 6.0 for 10 minutes when appropriate. Sections were 
blocked in 10% normal goat serum, 10% normal rabbit serum or 1% BSA in PBS for 1 
hour at room temperature, and then incubated with primary antibody overnight at 4°C. 
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Sections were rinsed with PBS 3 times for 10 minutes and then incubated with secondary 
antibody for 2 hours at room temperature. Sections were again rinsed 3 times for 10 
minutes and incubated with 100 ng/ml 4’,6-diamidine-2-phenylidole-dihydrochloride 
(DAPI) for 10 minutes at room temperature. Sections were rinsed 5 times for 5 minutes 
with PBS and mounted in a solution of 90% glycerol with p-phenylenediamine (Sigma, 
#P-6001). Sections were imaged using 10x and 20x objectives on a Nikon Eclipse 
TE2000-U inverted microscope. 
Primary antibodies used were goat anti-DESMIN (Santa Cruz Biotechnologies, 
#SC-34201, 1:200), mouse anti-PAX7 (Developmental Studies Hybridoma Bank, 1:50), 
mouse anti-PAX3 (R&D Systems, #MAB2457, 1:50), rabbit anti-LAMININ (Sigma, 
#L9393-.2ML, 1:400) and rabbit anti-FIBRONECTIN (Sigma, #F3648-.2ML, 1:400). 
Secondary antibodies used were Alexa Fluor 488 rabbit anti-goat IgG (Life Technologies, 
#A-11078, 1:1000), Alexa Fluor 488 goat anti-mouse IgG (Life Technologies, #A-11001, 
1:1000) and Alexa Fluor 568 goat anti-rabbit IgG (Life Technologies, #A-11011, 1:1000).  
 
Whole mount in situ hybridization 
E10.5 and 11.5 embryos were fixed in 4% PFA overnight, washed in 0.01% Tween-
20 in PBS (PBS-W), and dehydrated in a methanol series for storage at -20 °C until use. 
To generate antisense digoxygenin-labeled RNA probes, selected genes were amplified 
by RT-PCR from E10.5 mouse whole embryo cDNA. Gene-specific primers were 
designed using Primer3 (Rozen and Skaletsky, 1999) and then modified by adding the T7 
RNA polymerase binding site sequence (5’-CTAATACGACTCACTATAGGGAGA-3’) to the 
5’ end of the downstream primer. Generation of digoxigenin-labeled antisense RNA 
probes and in situ hybridization was carried out as described in Johnson et al. (2001). In 
situ hybridization was performed using an automated InsituPro (Intavis, LLC, San 
 56 
Marcos, CA), as described previously (Belo et al., 1997). Embryos were fixed in 4%PFA at 
4°C overnight. Embryos were photographed using a SMZ1000 stereodissecting 
microscope (Nikon) with a Retiga CCD digital camera (Q-Imaging). Some embryos were 
embedded, frozen and sectioned as described previously (Anderson et al., 2006), and 
sections were imaged using 10x and 20x objectives on a Nikon Eclipse TE2000-U 
inverted microscope. 
Probes used for WISH spanned the mouse mRNA regions from 588-1,310bp of 
the Itga4 transcript, 766-1,467bp of the Meox2 transcript, 1,421-2,002bp of the Dmrt2 
transcript, 2,973-3,733bp of the Itga6 transcript, 345-864bp of the Lbx1 transcript, 
2,479-3,098bp of the Met transcript, 864-1,463bp of the Eya2 transcript and 518-
1,260bp of the Six1 transcript. 
 
qPCR 
Forelimb-level dermomyotome/myotome tissue from E10.5 embryos, or limb 
bud tissue from E12.5 embryos, was microdissected from Paraxis+/+ and Paraxis-/- in 
cold PBS, individually flash frozen and stored at -80 °C until genotyping was completed. 
Total RNA was extracted with Trizol Reagent (Life Technologies, #15596018), and 
converted to cDNA with Superscript III (Life Technologies, #18080-044). QRT-PCR was 
performed on selected genes using Brilliant III Ultra Fast SYBR Green QPCR Master Mix 
(Agilent, #930882) on the ABI Prism 7900HT Sequence Detection System (Applied 
Biosystems). Cycling conditions were 95 °C for 3 minutes, followed by 45 cycles of 95 °C 
for 5s and 60 °C for 15s. Selected genes assayed were normalized to Gapdh expression 
levels. Statistical analysis on expression data was carried out on relative expression levels 
for 3 wild type and 3 Paraxis-/- samples using a nonparametric Mann-Whitney test with 
p ≤ 0.05.  
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Neonate histology 
2 wild type and 2 Paraxis-/- neonates were collected immediately after birth, 
euthanized and fixed in 95% ethanol overnight at 4°C. Neonates were dehydrated in an 
ethanol series and embedded in paraffin for sectioning. 15uM sections were collected 
along the length of each limb and dried overnight. Select sections representing 
comparable limb landmarks were subjected to hematoxylin and eosin staining. 
Representative images of all four limbs were obtained using 4x and 10x objectives on a 
Nikon Eclipse TE2000-U inverted microscope. Limb structures were identified using the 
Mouse Limb Anatomy Atlas (April DeLaurier, 2008). 
 
Luciferase Reporter Assay 
An 816bp promoter region encompassing the -18kb Pax3 hypaxial enhancer 
(Brown et al., 2005) was PCR amplified and sublconed into the XhoI/Kpn1 sites of 
pGL3Promoter plasmid (Promega, Madison, WI).  The PARAXIS coding sequence was 
subcloned into the XhoI/XbaI sites of the CS2-MT plasmid to create the fusion proteins 
MT-PARAXIS. The eGFP coding sequence was subcloned into the BamHI/StuI sites of 
CS2, and E12 was subcloned into the EMSV vector. All clones were sequenced for 
verification. C2C12 myoblasts/CD1 mouse satellite cells were seeded at 6x104 cells/well 
in complete media [DMEM/Ham’s F-10 supplemented with 10% Newborn Calf 
Serum/20% Fetal Bovine Serum] in 24-well tissue-culture dishes.  After 18 hours, each 
well was transfected with a total of 500 ng of plasmid DNA using 0.5 µl of X-tremeGENE 
HP DNA Transfection Reagent (Roche, #06366244001), for a 1:1 DNA:transfection 
reagent ratio. Transfected cells were lysed 48 hours post-transfection in 100 µl/well 
Luciferase Cell Culture Lysis Buffer (Promega, Madison, WI) and subjected to a single 
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freeze-thaw cycle at -80oC.  Luciferase activity was measured for each well by reacting 20 
µl of cell lysate with 100 µl of Luciferase Assay Buffer (Promega, Madison, WI) in white 
96-well plates, using an FLx800 microplate reader (BioTek Instruments, Inc., Winooski, 
VT).  The experiment was performed in triplicate, and fold-change was calculated 
relative to luciferase activity levels derived from the Pax3 Hypaxial Enhancer-pGL3P 
vector co-transfected with expression vectors encoding only the myc peptide. 
 
Results 
The localization of myocytes and muscle structural proteins is disrupted in the Paraxis-
/- myotome. 
 The -1565 Myogenin-LacZ transgene was bred into the Paraxis+/- mouse line, 
which allows us to visualize differentiating myocytes in the absence of PARAXIS (Cheng 
et al., 1992).  The forelimb-level myotomes of E9.5 Paraxis-/- mice stained for β-
galactosidase activity appeared disorganized and compact (Figure 2B) compared to wild 
type (Figure 2A). Sagittal sections revealed that most of the individual myocytes are 
centrally located and do not extend to the anterior and posterior borders of the 
myotome.  In some cases, myocytes appear to span the borders between adjacent 
myotomes (arrowheads in Figure 2D).  The myotome was broader along the medial-
lateral axis in the Paraxis-/- embryos when compared to the wild type myotome (Figure 
2E and F), suggesting that the myocytes are not tightly associated with the 
dermomyotome. These results suggest that the correct localization and orientation of 
differentiating myocytes depends upon the activity of PARAXIS. 
We next examined the distribution of the intermediate filament protein, DESMIN, in the 
anterior myotome of Paraxis-/- embryos by indirect immunofluorescence. DESMIN is 
concentrated at the tips of elongating myocytes, where it is thought to promote binding  
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Figure 2. Myocyte orientation and protein localization is disrupted in the Paraxis-/- 
myotome. E9.5 wild type (A, C, E) and Paraxis-/- (B, D, F) embryos carrying a -
1565Myogenin-LacZ transgene were stained for β-galactosidase activity. Whole mount 
embryos (A and B) display disorganized myotomes in the absence of Paraxis. Sagittal 
sections (C and D) through anterior somites reveal a general lack of myocyte elongation, 
with occasional myocyte extension beyond somite borders (purple arrowheads) in 
Paraxis-/- embryos. Transverse sections (E and F) through anterior somites demonstrate 
a medial-lateral extension of the myotome in Paraxis-/- embryos. Immunofluorescent 
staining for DESMIN in wild type (G) and Paraxis-/- (H) embryos reveals mislocalization 
of the intermediate filament protein from the tips of elongating myocytes in mutant 
embryos. 
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to the ECM within the myotendinous junctions that form between somites (Towler, 
2004; Wang et al., 2013). DESMIN was located throughout the elongated myocyte in 
wild type embryos, however, it was most highly concentrated at the anterior and 
posterior tips of the myocytes (Figure 2G). In embryos lacking Paraxis, DESMIN was 
distributed evenly throughout the disorganized myocytes, and did not appear to be 
concentrated at the tips (Figure 2H).This result suggests that the proper distribution of 
anchoring proteins at the ends of myocytes is altered in the absence of Paraxis 
expression, and that this may contribute to the misalignment of myocytes in the Paraxis-
/- myotome. This observation also raises the possibility that Paraxis-/- myofibers have a 
functional defect, as DESMIN localization is important for mechanical integrity and 
contractility (Li, 1997).  
 The integrin α4 subunit is another protein expressed in elongating myocytes 
within the myotome, and thought to be involved in the extension and anchoring of 
myocytes to the fibronectin-rich borders of somites. In whole mount in situ hybridization 
(WISH) of E10.5 wild type embryos, Itga4 expression was noted in both the epaxial and 
hypaxial myotome regions (Figure 3A). Using qPCR, we observed that Itga4 
transcription was reduced 5-fold in Paraxis-/- myotomes (Figure 3C). WISH revealed 
that the loss of Itga4 was localized to the epaxial myotome in the dorsal half of the 
somite, while the hypaxial myotome expression appeared largely unchanged in the E10.5 
Paraxis-/- embryos (Figure 3B). These data demonstrate that PARAXIS activity is 
required for the expression of proteins involved in myocyte-ECM interactions in the 
myotome, and that the disruption of these interactions may cause a lack of myocyte 
extension and anchorage. 
 
Muscle lineage specification in the dermomyotome is disrupted in Paraxis-/- embryos. 
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 Figure 3. Itga4 expression is downregulated in the epaxial myotome of Paraxis-/- 
embryos. Whole mount in situ hybridization (WISH) was performed on E10.5 wild type 
(A) and Paraxis-/- (B) embryos with a probe specific for Itga4 mRNA. Staining in the 
epaxial myotome of forelimb-level somites is not visible in the absence of Paraxis. 
Quantification of the downregulation in mutant embryos by qPCR revealed a 20% 
reduction in expression level, relative to wild type embryos. 
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The disorganization of myocytes and structural proteins in the myotomes of Paraxis-/- 
embryos may be due to the disruption of the somitic compartment from which they are 
derived: the dermomyotome. It has been known for some time that Paraxis-/- embryos 
do not possess epithelial dermomyotomes (Burgess et al., 1996), but the specification of 
these cells has not been examined in depth. To address this, we used indirect 
immunofluorescence to assess the expression levels of PAX7 and PAX3, which are 
concentrated in different regions of the dermomyotome of E10.5 embryos. PAX7 was 
distributed throughout the central dermomyotome of wild type embryos (Figure 4A). 
Cells in the region of the dermomyotome of Paraxis-/- embryos expressed PAX7 at a level 
that appeared similar to wild type embryos, though the cells were dispersed over a wider 
area (Figure 4B). Expression of PAX3, on the other hand, which is predominantly 
localized to the DML and VLL in wild type embryos (Figure 4C), was significantly 
reduced in mutant embryo dermomyotomes (Figure 4D and G), supporting the previous 
finding of a decrease in Pax3 transcription in embryos lacking Paraxis (Wilson-Rawls et 
al., 1999). Small patches and individual cells stained positive for PAX3 in the region of 
the Paraxis-/- dermomyotome, but the staining was not as robust or as concentrated as in 
wild type embryos. These results indicate that the PAX3+ve myogenic cells of the DML 
and VLL are improperly specified in the Paraxis-/- dermomyotome region, but that the 
PAX7+ve MPCs of the central dermomyotome are specified and may compensate for a 
lack of PAX3 in the developing trunk muscles.  
 MEOX2 directs epaxial dermomyotome myogenic specification via the regulation 
of Pax3 expression. In order to determine if the decrease in PAX3 expression in Paraxis-
/- embryos was due to misregulation of this pathway, we performed WISH with a probe 
specific for Meox2. Wild type E10.5 embryos express Meox2 in the DML of the forelimb-
level dermomyotome (Figures 4E and 8A), while Meox2 expression is nearly abolished in  
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Figure 4. Dermomyotome specification is partially disrupted in Paraxis-/- embryos. 
Section immunofluorescence for PAX7 (A and B) and PAX3 (C and D) reveal similar 
levels of PAX7 expression in E10.5 wild type (A) and Paraxis-/- (B) dermomyotomes. 
However, there is a dramatic decrease in the number of PAX3-positive cells in the 
dermomyotomes of mutant embryos (D), compared to wild type embryos (C). WISH 
with a probe specific for Meox2 (E and F) reveals a nearly complete ablation of Meox2 
expression in E10.5 forelimb-level dermomyotomes lacking Paraxis expression. 
Quantification of Pax3 and Meox2 transcription levels (G) shows them significantly 
decreased in Paraxis-/- embryos. Image magnification in A-D is 100x. 
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the absence of Paraxis (Figures 4F and 8B). Quantification of Meox2 transcription levels 
revealed that expression is more than 80% reduced in Paraxis-/- dermomyotomes 
(Figure 4G). This raises the possibility that PARAXIS may regulate PAX3 expression in 
the epaxial dermomyotome indirectly through MEOX2. 
 
The myotomal basal lamina does not form in the absence of Paraxis expression. 
 During initial myotome formation, PAX3 directly activates the expression of the 
transcription factor DMRT2 in the dermomyotome. DMRT2 is involved both in laminin 
production and, indirectly, in the myoblast expression of integrin α6β1, which binds 
laminin and organizes it into a myotomal basement membrane (Bajanca, 2006; Sato et 
al., 2010; Seo et al., 2006). PARAXIS activates Dmrt2 expression in the newly formed 
somite, where it organizes the basement membrane surrounding the somites (Rowton et 
al., 2013). To determine whether PARAXIS also regulates Dmrt2 expression in the 
dermomyotome, we performed WISH on E9.5 embryos. Dmrt2 transcripts were detected 
throughout the dermomyotomes of wild type embryos (Figure 5A), yet appeared 
completely absent from Paraxis-/- embryos (Figure 5B). Immunofluorescent detection of 
laminin demonstrated that Paraxis-/- embryos produce laminin protein in the mature 
somite, but that it is not organized into a basal lamina separating the myotome from the 
sclerotome compartments (Figure 5D), as it is in wild type embryos (green arrowheads in 
Figure 5C). These results suggest that the disruption in myotomal basal lamina 
formation in Paraxis-/- embryos is associated with a dramatic downregulation of Dmrt2 
expression, but that it is not due to a lack of laminin production. 
 To examine whether basal lamina disruption is due, instead, to the misregulation 
of integrin α6β1 in the Paraxis-/- myotome, we performed WISH with a probe specific for 
Itga6. Indeed, E10.5 wild type embryos expressed Itga6 strongly in the myotome (Figure  
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Figure 5. Myotomal basal lamina formation is disrupted in the absence of Paraxis 
expression. Dmrt2 expression is severely downregulated in E10.5 mutant embryos (B), 
as compared to wild type embryos (A) and detected by WISH. Immunofluorescence 
reveals that laminin is present, but disorganized, and does not form a basal lamina 
(arrowheads in C) in mutant embryos (D). Itga6 expression is decreased in the 
myotomes of Paraxis-/- embryos (F and H), compared to wild type embryos (E and G). 
Itga6 expression in E10.5 myotomes was reduced by 20% in Paraxis-/- embryos, relative 
to wild type levels (I). 
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5E, G), while Paraxis-/- embryos did not (Figure 5F, H). This downregulation was 
quantified as a nearly 20% reduction by qPCR (Figure 5I). The downregulation of Dmrt2 
and Itga6 in embryos lacking Paraxis indicates that PARAXIS controls myotome basal 
lamina formation through the activation of a Pax3/Dmrt2/integrin α6β1 pathway. 
Together, observations of Paraxis-/- myotome formation suggest that PARAXIS directs 
epaxial myotome organization through the PAX3-dependent expression of myoblast cell-
surface receptors that bind to, and shape, the surrounding ECM.  
 
Forelimb musculature is absent or hypoplastic in Paraxis-/- neonates. 
 It has been demonstrated that Paraxis-/- embryos display an approximately 2 day 
delay in hypaxial myotome formation that is thought to then be compensated for by 
MYF5-positive myocytes of epaxial origin, resulting in normal neonatal limb 
musculature (Wilson-Rawls et al., 1999). Given the dramatic disorganization of the 
myotome in E10.5 Paraxis-/- embryos, we hypothesized that PARAXIS may be required 
for the normal migration of MPCs to the limbs. To test this, we examined the 
musculature of E18.5 wild type and Paraxis-/- limbs in H&E-stained sections. Muscles of 
the Paraxis-/- forelimb displayed varied malformations. Dorsal and ventral muscles of 
the forelimb zeugopod were unidentifiable in Paraxis-/- neonates (Figure 6B), as 
compared to wild type neonates (Figure 6A).  The presence of small myofibers was 
evident (green arrowhead in Figure 6B inset), but larger fasciculi and intact muscle 
groups were absent. Furthermore, a large number of adipocytes were present within the 
area normally occupied by muscle groups in mutant limbs (yellow arrowhead in Figure 
6B inset).  
Unlike the forelimb zeugopod, all of the muscles of the proximal forelimb were 
present in Paraxis-/- neonates. However, the muscles of the dorsal triceps muscle group  
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Figure 6. Select forelimb musculature is absent or hypoplastic in Paraxis-/- neonates. 
H&E staining of distal forelimb sections of wild type (A) and mutant (B) neonate 
forelimbs reveals very few myofibers in Paraxis-/- neonates (green arrowhead), and an 
increase in adipocyte abundance (yellow arrowhead). Sections through proximal 
forelimbs demonstrate hypoplastic triceps muscles (to the right of the humerus) in 
mutant embryos. Images in A-D are taken at 40x magnification, except for the insets, 
which are at 100x.  
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were hypoplastic (Figure 6C and D), The ventrally-located biceps and brachialis muscles 
appeared similar in size to wild type muscles, suggesting that the muscle defect was 
specific to those on the dorsal aspect of the limb. The muscles of the Paraxis-/- forelimb 
stylopod were also surrounded by an overabundance of adipocytes not present in wild 
type limbs. Muscles of the hindlimb zeugopod and stylopod of neonates lacking 
PARAXIS were indistinguishable from wild type muscles, with no obvious defects in 
myogenesis or patterning (data not shown). Together, the defects observed in the distal 
and proximal forelimb of Paraxis-/- neonates indicate varied effects of PARAXIS activity 
that are specific to the different limb regions, and are essential for proper appendicular 
muscle development.  
 
A reduced number of myogenic progenitor cells populate the developing limbs of 
Paraxis-/- embryos. 
To identify the origin of the myogenesis defects seen in the forelimbs of neonates 
lacking Paraxis, we evaluated the progress of myogenesis in the developing limbs of 
E12.5 wild type and Paraxis-/- embryos. Sagittal sections through the developing limbs of 
E12.5 Paraxis-/- embryos carrying the -1565 Myogenin-LacZ transgene indicate that limb 
myogenesis is disrupted as early as E12.5. Robust muscle masses are present in both the 
dorsal and ventral aspects of the developing forelimb and hindlimb of wild type embryos, 
surrounding the condensing cartilage primordia at the center of the limbs (Figure 7A, C). 
Mutant embryos, on the other hand, possess fewer differentiating myocytes in the dorsal 
and ventral muscle masses of both limbs (Figure 7B, D). Indeed, MYOGENIN-positive 
cells are nearly absent from Paraxis-/- hindlimb sections at E12.5 (Figure 7D).  
 Quantification of the total number of MYOGENIN-positive cells in the limb 
reveals a deficit of approximately 60% in the forelimb and 80% in the hindlimb of 
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embryos lacking Paraxis, relative to wild type limbs (Figure 7E). Further, when they are 
considered separately, the dorsal and ventral muscle masses of Paraxis-/- embryos reveal 
an interesting difference. While both the dorsal and ventral muscle masses of mutant 
embryo forelimbs and hindlimbs possess fewer differentiating myocytes than their wild 
type counterparts, a greater deficit is seen in the dorsal muscle mass of the E12.5 
forelimb than in the ventral muscle mass (Figure 7F). This is consistent with the 
hypoplasia of the dorsal musculature in Paraxis-/- forelimb stylopods. This 
dorsal/ventral difference is not observed in the developing hindlimb muscle masses, 
which is also consistent with neonatal results. These results indicate that PARAXIS 
activity has an effect on the proper number of differentiating myocytes in the developing 
forelimb and hindlimb, and that this effect is especially pronounced in the dorsal muscle 
mass of the E12.5 forelimb. 
 
Proliferation of MPCs and ECM organization in Paraxis-/- limbs is not disrupted. 
 PAX3 activity is required for all of the stages of limb myogenesis prior to 
differentiation. Because Pax3 limb expression is downregulated in the absence of 
Paraxis, a deficit in the number of MYOGENIN+ve myocytes in the developing limbs of 
Paraxis-/- embryos could derive from one of these PAX3-dependent stages, including 
MPC proliferation within the limb, migration into the limb bud or delamination from the 
VLL of the hypaxial dermomyotome. In order to address the possibility of an MPC 
proliferation defect in embryos lacking Paraxis, we performed WISH on E10.5 wild type 
and Paraxis-/- embryos with a probe specific for Meox2, which is expressed in 
proliferating limb MPCs. E10.5 wild type embryos express Meox2 strongly in the forming 
dorsal muscle mass and, to a lesser extent, the ventral muscle mass (Figure 8A). While 
Paraxis-/- embryos lack Meox2 expression in the dermomyotome, expression of the  
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Figure 7. Myocyte number is reduced in the limbs of embryos lacking Paraxis at E12.5. β-
galactosidase staining of E12.5 embryo limbs (A-D) demonstrates a reduced number of 
differentiating myocytes in Paraxis-/- forelimbs (B) and hindlimbs (D), as compared to 
wild type forelimbs (A) and hindlimbs (C). Quantification of MYOGENIN-positive cells 
(E) reveals a significant decrease in MPC number in mutant forelimbs (T-test: t4.0 = 
1003.8, P = 0.007) and hindlimbs (T-test: t4.0 = 1137.6, P = 0.005). The percentage of 
dorsal MPCs in the Paraxis-/- forelimb is reduced to a greater extent than other limb 
regions (F). 
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transcription factor in the E10.5 limb is not reduced (Figure 8B). In fact, a quantitative 
analysis of Meox2 expression levels in the limb indicates that it is slightly upregulated in 
the absence of Paraxis (Figure 8C), raising the possibility that Meox2 is upregulated in 
response to the decrease in MPC number. The maintenance of Meox2 expression in the 
developing limb of Paraxis-/- embryos suggests that the deficit in differentiatingmyocytes 
observed in E12.5 limbs is not due to a defect in MPC proliferation. 
 Next, we sought to determine if Paraxis-/- limb MPCs had a reduced migratory 
ability. MPC colonization of the limb is dependent upon the proper production and 
organization of fibronectin and laminin into a scaffold along which integrin-expressing 
MPCs can migrate. Because Paraxis-/- embryos display compromised receptor-driven 
ECM organization in the newly forming somites (Rowton et al., 2013) and the epaxial 
myotome, we hypothesized that migratory MPCs also failed to properly shape the ECM 
in mutant embryo limbs. Fibronectin is expressed throughout the developing limb buds 
of both wild type (Figure 9A) and Paraxis-/- (Figure 9B) E10.5 embryos, as assessed by 
immunofluorescence. Laminin expression surrounding the surface ectoderm and blood 
vessels of the Paraxis-/- limb (Figure 9D) also appears identical to that of wild type 
embryos (Figure 9C). Normal localization of fibronectin and laminin in the developing 
limb mesenchyme of embryos lacking Paraxis suggests that MPC migration into the 
limbs of these embryos is not inhibited by a defect in receptor-driven organization of 
fibronectin and laminin, and may instead be mediated by another form of cell-
environment interaction. 
 
PAX3/MET/LBX1-dependent hypaxial EMT and migration do not occur in Paraxis-/- 
embryos. 
 Migratory limb MPCs require the expression of the PAX3-dependent  
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Figure 8. Meox2 is expressed in the limbs of Paraxis-/- embryos. WISH performed on 
E10.5 wild type (A) and Paraxis-/- (B) embryos demonstrates that Meox2 expression is 
present in the limbs of mutants, while it is absent from the DML of the dermomyotome 
(blue arrowheads). Meox2 transcripts are also present in E12.5 Paraxis-/- limb tissue, as 
measured by qPCR (C).  
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Figure 9. Fibronectin and laminin are normally localized in the limbs of Paraxis-/- 
embryos. Fibronectin (A and B) staining appears normally distributed in the limb buds 
of E10.5 Paraxis-/- embryos (B), as compared to wild type embryos (A). Laminin is 
localized to the surface ectoderm and blood vessels within the limb buds of both wild 
type (C) and Paraxis-/- (D) embryos. Image magnification is 100x. 
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transcription factor LBX1 in order to migrate away from the hypaxial dermomyotome 
and towards the limb (Brohmann et al., 2000; Gross et al., 2000). LBX1+ve cells express 
the cytokine receptor CXCR4, whose ligand, SDF1, is expressed in the limb mesenchyme 
and attracts MPCs into the limb (Vasyutina, 2005). To assess the involvement of LBX1 
activity in the Paraxis-/- limb muscle defect, we examined the expression of Lbx1 in the 
mutant embryo. Lbx1 is expressed in MPCs migrating towards the neck, heart, 
diaphragm and both limb buds in wild type embryos (Figure 10A, C and E). We observed 
a nearly complete ablation of Lbx1 expression in the Paraxis-/- embryo (Figure 10B, D 
and F) using WISH. When measured quantitatively, Lbx1 expression is reduced by 40% 
in the E10.5 hypaxial dermomyotome and 70% E12.5 limb (Figure 10M and N).  
 The migration of limb MPCs is dependent upon their earlier delamination from 
the epithelial VLL of the dermomyotome. This EMT requires the activation of the MET 
receptor in MPCs by its ligand HGF/SF, which is expressed by the limb bud 
mesenchyme. Met expression is known to require activation by PAX3 in hypaxial MPCs 
(Yang et al., 1996), so we evaluated the expression domain and level of Met in Paraxis-/- 
embryos. Met transcripts were noted in the DML and VLL of the wild type 
dermomyotome, as well as the forelimb and hindlimb buds at E10.5 (Figure 10G, I, K). In 
the absence of Paraxis, Met expression was undetectable in all of these regions, as 
assessed by WISH (Figure 10H, J, L). Quantification of this reduction confirmed that 
Met transcript levels were reduced by approximately 30% in E10.5 hypaxial 
dermomyotomes and that the 30% reduction was maintained in E12.5 limbs (Figure 
10M, N). We confirmed that HGF/SF is expressed normally in the Paraxis-/- limb (data 
not shown), indicating that any defect in delamination from the VLL would be caused by 
the misregulation of the MET receptor, rather than its ligand, rendering the cells 
unresponsive to proper HGF signaling. 
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Figure 10. The expression of Lbx1 and Met are reduced in embryos lacking Paraxis. Lbx1 
expression (A-F) is severely reduced in the forelimb (C and D) and hindlimb (E and F) 
buds of E10.5 Paraxis-/- embryos, as compared to wild type. Met expression is similarly 
reduced (G-L). Quantification of Lbx1 and Met in E10.5 somite (M) and E12.5 limb (N) 
tissue reveals that the decrease in expression is significant, and that it does not recover 
by E12.5. 
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To confirm that migratory MPCs of the Paraxis-/- dermomyotome exhibit a 
delamination defect caused by a lack of Pax3 expression, we examined the number of 
delaminating MPCs expressing PAX3 in cells near the VLL. Immunofluorescence 
revealed that many PAX3-expressing MPCs undergo EMT in the hypaxial 
dermomyotome (blue arrowhead) and migrate to colonize the limb bud (red arrowheads 
in Figure 11A). In mutant embryos that lack an epithelial dermomyotome, however, only 
a few cells express PAX3 in the hypaxial region and the limb bud (Figure 11B). By E12.5, 
levels of Pax3 transcription in the Paraxis-/- limb are reduced by approximately 50% 
(Figure 11C). The severe reduction in Pax3, Met and Lbx1 expression in Paraxis-/- 
embryos predicts that the appendicular muscle defects seen in the mutant forelimbs are 
caused by fewer MPCs delaminating from the dermomyotome and migrating into the 
limb. It is possible that the epithelial morphology of the dermomyotome is necessary for 
proper MPC gene expression and EMT, and that the lack of an epithelial dermomyotome 
in the absence of Paraxis expression causes MPCs to be incapable of responding to the 
migration-promoting signals emanating from the limb bud.  
 
PARAXIS regulates the expression of Pax3 in the hypaxial dermomyotome directly, and 
indirectly through the transcription factors EYA2, SIX1 and SIX4. 
 Expression of Pax3 in the hypaxial dermomyotome and migrating MPCs is 
dependent upon a hypaxial enhancer found within the Pax3 promoter, -18kb from the 
transcriptional start site (Brown et al., 2005). Due to the reduction of Pax3 expression in 
the hypaxial myoblasts of Paraxis-/- embryos, and the presence of four Eboxes within 
and surrounding the Pax3 hypaxial enhancer, we tested the possibility that PARAXIS 
directly controls the expression of Pax3 from this enhancer. An 816bp promoter region 
including the enhancer was cloned upstream of the SV40 promoter driving expression of  
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Figure 11. Fewer PAX3-positive cells populate the limb buds of Paraxis-/- embryos. 
Embryos lacking Paraxis expression (B) have very few PAX3-positive cells in the regions 
of the dermomyotome and limb buds, while wild type embryos (A) display several 
delaminating (blue arrowhead) and migrating (red arrowheads) PAX3-positive MPCs. 
Image magnification is 100x. Quantification of Pax3 transcription levels demonstrates a 
50% reduction in expression level in the absence of Paraxis expression (C).  
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a luciferase reporter gene, and was transfected into two myogenic cell lines along with 
expression vectors containing the coding sequence of myc-tagged PARAXIS and its 
putative binding partner, E12.  
In both primary satellite cells and C2C12 myoblasts transfected with an empty 
pGL3p vector, no combination of transcription factors was able to activate the expression 
of luciferase (Figure 12A and B). When transfected with pGL3p containing the Pax3 
hypaxial enhancer, however, both E12 and PARAXIS alone were able to activate the 
transcription of luciferase. In satellite cells, the co-transfection of E12 and PARAXIS, led 
to the largest fold increase in luciferase activity, though this fold increase was not 
significantly higher than that caused by the transfection of PARAXIS alone (Figure 12A). 
In C2C12s, E12 and PARAXIS synergy led to the highest fold-increase of 4.7-fold (Figure 
12B), and this increase was greater than those caused by either protein alone. These 
results suggest that PARAXIS directly activates transcription from the Pax3 hypaxial 
enhancer, and that it can do so as a homodimer or heterodimer, depending on its cellular 
context. 
 While no other transcription factors have yet been shown to activate Pax3 
transcription from this enhancer, EYA2 and SIX1/4 combine to affect Pax3 expression in 
the hypaxial dermomyotome and migrating MPCs. To examine whether PARAXIS may 
also activate Pax3 expression indirectly, through the activation of these transcription 
factors, we used WISH and qPCR to evaluate their expression levels in the absence of 
Paraxis. The expression of Eya2 was weaker in the epaxial and hypaxial lips of the 
dermomyotomes of Paraxis-/- E10.5 embryos (Figure 13B), relative to wild type embryos 
(Figure 13A). The downregulation of Eya2 was also reflected in the lack of Eya2-
expressing MPCs migrating into the limb buds of mutant embryos (Figure 13A and B), 
and was confirmed by qPCR, where it was suppressed by more than 50% (Figure 13E). 
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Figure 12. PARAXIS can activate transcription from the Pax3 hypaxial enhancer in 
myogenic cell lines. Mouse satellite cells (A) were co-transfected with a plasmid 
containing the Pax3 hypaxial enhancer and plasmids encoding a 6x myc-tag (MT), E12 
and PARAXIS in different combinations. Cells transfected with PARAXIS and 
PARAXIS/E12 displayed a 2-fold increase in luciferase activity. C2C12 myoblasts (B) 
were transfected similarly. C2C12s transfected with E12 and PARAXIS/E12 displayed a 
3.8 and 4.7-fold increase in luciferase activity, respectively. 
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Six1 expression in the dermomyotome was similarly downregulated in E10.5 embryos 
lacking Paraxis (Figure 13C and D). Limb bud expression of Six1 did not only seem to 
reflect the presence of migratory MPCs, but was also expressed in a more posterior 
domain of the developing limb (Figure 13C). In Paraxis-/- embryos, Six1 expression in 
this posterior domain was maintained, while the MPC domain was not, probably due to a 
lack of migratory MPCs (Figure 13D). Both Six1 and Six4 were downregulated by 30% in 
Paraxis-/- myotomes (Figure 13E). These results demonstrate that PARAXIS is required 
for proper expression of the Pax3 regulators EYA2 and SIX1/4, suggesting that PARAXIS 
may indirectly control Pax3 expression in the hypaxial dermomyotome through the 
activation of intermediate regulators. 
PARAXIS expression is excluded from myoblasts during early events in 
embryogenesis, however, its activity is required for the proper development of epaxial 
and hypaxial skeletal muscle. Epaxial myoblasts in mutant embryos colonize the 
myotome in a disorganized manner, while hypaxial myotome formation and MPC 
migration is delayed (Wilson-Rawls et al., 1999). Here, we have sought to determine the 
mechanism by which PARAXIS regulates muscle development. Previous studies 
predicted that downregulation of PAX3 in the absence of PARAXIS could participate in 
these processes.  Here we performed a more in depth study of the ECM, ECM receptors 
and transcription factors associated with early myogenesis.  We found that, in fact, many 
downstream targets of PAX3 are also downregulated in Paraxis-/- embryos, strongly 
supporting the importance of PAX3 regulation in the Paraxis-/- phenotype.  However, 
there are some distinctions between PAX3 regulation in the myotome and the limb buds 
that raise the possibility of a complex regulatory network in which PARAXIS induces the 
transcription of PAX3 through varied mechanisms. 
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Figure 13. Eya2 and Six1 expression is decreased in Paraxis-/- embryos. WISH reveals 
lower levels of Eya2 (A and B) and Six1 (C and D) expression in the limb buds of E10.5 
mutant embryos, compared to wild type embryos. Quantification of expression level in 
E10.5 somite tissue confirms the downregulation of Eya2, Six1 and Six4 in the absence of 
Paraxis (E).   
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Discussion 
PARAXIS regulates the expression of ECM receptors during initial myotome formation 
The formation of the myotomal basal lamina is critical to myotome organization, as it 
provides a scaffold for myocytes extending from anterior to posterior in a parallel fashion 
with central nuclei (Anderson et al., 2009; Seo et al., 2006; Tajbakhsh et al., 1996). 
Paraxis-/- myotomes are disorganized, with myocytes that fail to extend to the full somite 
width, cross and expand medially as a group to invade the sclerotome compartment. 
Based on our understanding of myotome formation, the Paraxis-/- phenotype is 
consistent with defective basal lamina formation or the inability of myocytes to bind to 
the extracellular matrix proteins of the basal lamina. We present evidence suggesting 
that both deficits may be occurring in the Paraxis-/- somites, including the reduction of 
Dmrt2 expression required for laminin expression, disruption to the organization of the 
existing laminin, and reduction of Itga6 expression.  ITGA6 is a component of the 
integrin α6β1, which is the only laminin-specific receptor expressed in the early myotome 
(Bajanca et al., 2004). Inactivation of Itga6 leads to the medial spreading of myocytes 
(Bajanca, 2006), similar to what was observed in the Paraxis-/- somites.  The α4 subunit 
of the integrin α4β1 is also downregulated in the Paraxis mutants.  Integrin α4β1 is 
normally expressed on elongating myocyte tips where it binds fibronectin in the basal 
lamina (Wayner et al., 1989; Bajanca et al., 2004), and the inhibition of fibronectin 
between somites leads to a disruption in myofiber organization in zebrafish embryos 
(Snow et al., 2008). Overall, these studies predict that PARAXIS participates in 
establishing the morphology of the early myotome through the regulation of the laminin 
scaffold and the production of integrin receptors that mediate myocyte binding.    
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PARAXIS regulates the expression of receptors and transcription factors required for 
MPC EMT and migration into the limb bud 
Paraxis-/- embryos exhibit a delay in MYOD-regulated hypaxial myogenesis and 
MPC migration into the limb bud. However, it has been suggested that this defect is 
compensated by MYF5+ myoblasts of epaxial origin by E12.5 (Wilson-Rawls et al., 1999). 
Here, we have shown that, while certain aspects of appendicular myogenesis are rescued 
in Paraxis-/- embryos, not all of the effects of delayed hypaxial myogenesis are overcome. 
Specifically, Paraxis-/- neonates are born with hypoplastic dorsal forelimb stylopod 
muscles and an absence of forelimb zeugopod muscles, and these defects are reflected in 
a reduction in MPC number within the limb at E12.5. The specificity of the musculature 
defects seen in Paraxis-/- neonates is reminiscent of Lbx1 and Met mutants, which also 
display defects only in certain muscle groups (Gross et al., 2000; Schafer and Braun, 
1999).  Similar to Paraxis-/- neonates, the dorsal limb muscles, rather than the ventral 
muscles, of Lbx1-/- mice are especially affected (Gross et al., 2000; Schafer and Braun, 
1999). Furthermore, partially compromising MET receptor function in mouse embryos 
results in defects in particular forelimb muscles at E15.5 (Maina et al., 2001). The 
similarities between the specificity of LBX1, MET and PARAXIS activity suggest that 
these transcription factors participate in the same genetic pathway to regulate 
appendicular muscle development. This was supported by the observation that Lbx1 and 
Met expression are dramatically downregulated in the absence of Paraxis. The 
misregulation of both genes points to a role for PARAXIS in two distinct processes: the 
delamination of MPCs from the VLL of the dermomyotome, and the migration of MPCs 
away from the somite and into the limb bud. 
Our expression studies reveal the importance of PARAXIS in the activation of a 
PAX3-dependent pathway controlling myotome and limb muscle development. This is 
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occurring, at least in part, through the regulation of Pax3 transcription by PARAXIS.  
However, it is interesting to note that other critical regulators of PAX3 are also 
misregulated in the Paraxis-/- embryos. More specifically, MEOX2, which regulates Pax3 
expression in the dermomyotome and migrating MPCs is expressed in the 
dermomyotome, but not the limb buds of Paraxis-/- embryos. This suggests that 
PARAXIS may regulate epaxial Pax3 expression indirectly through a MEOX2-dependent 
pathway. Further, Eya2 and Six1/Six4, encoding known regulators of Pax3 expression, 
are also downregulated in Paraxis-/- embryos. Evidence for the ability of SIX1 to bind the 
Pax3 hypaxial enhancer (Grifone et al., 2007) indicates that, in vivo, PARAXIS and SIX1 
may both bind the enhancer and activate it cooperatively.  Collectively, this reveals the 
potential for a complex feedback loop between PARAXIS and PAX3 in the regulation of 
early myogenesis. 
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Chapter 4 
Conclusions 
 
The transcription factor PARAXIS has been shown to be essential for the 
development of the vertebrate musculoskeletal system. Previous studies have implicated 
the gene in MET and the proliferation and specification of the MPCs that migrate into 
the limb buds.  This work has sought to elucidate the genetic hierarchies within which 
PARAXIS functions during somitogenesis and muscle development. We have found that 
PARAXIS regulates the expression of genes important for interactions between cells and 
their environment. PARAXIS directs epithelialization during somitogenesis by activating 
receptors that organize the ECM surrounding forming somites. Through participation in 
PAX3-dependent pathways, PARAXIS regulates the expression of similar receptors 
during muscle development, in addition to receptors that bind diffusible morphogens. 
The identification of PARAXIS targets enables us to better understand the mechanisms 
by which transcription factors control the morphogenesis of the mesodermal lineages. 
Advances in this field can ultimately be used in the pursuit of treatments and 
preventions for congenital diseases of the musculoskeletal system. 
 
Paraxis is a vertebrate-specific transcription factor. 
 The evolutionary history of Paraxis can provide additional clues as to its present-
day function in vertebrates. Paraxis and its sister gene, Scleraxis, only exist within the 
genomes of vertebrates, most likely duplicating and diverging during one of the two 
vertebrate-specific genome duplications. When comparing the amino acid divergence of 
mouse PARAXIS, SCLERAXIS and the Drosophila PARASCLERAXIS orthologue (Figure 
1A), the bHLH domains retain a high degree of homology.  A comparison of the bHLH  
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Figure 1. Evolutionary relationships of mouse PARAXIS, SCLERAXIS, Drosophila and 
PARASCLERAXIS proteins. Amino acid sequences for mouse PARAXIS and SCLERAXIS 
and Drosophila PARASCLERAXIS were aligned (A) using ClustalW. Asterisks denote 
conserved residues, while colons and periods denote semi-conserved residues. The 
bHLH region is highlighted in red. Evolutionary histories of complete proteins (B) and of 
bHLH regions (C), including TWIST, were inferred using the Maximum Likelihood and 
Neighbor-Joining methods in PhyML and MEGA4, respectively. A JTT model of amino 
acid substitution was used, and the rate variation among sites was modeled with a 
gamma distribution (shape parameter was estimated to be 0.70 for the complete 
alignment and 0.28 for the bHLH region alignment).  Sequence alignment was 
constructed using the MAFFT software. 
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domain and full-length protein across basal chordates and protostomes revealed that 
PARASCLERAXIS is more closely related to PARAXIS and SCLERAXIS than to TWIST, 
their closest family member (Figure 1B and C).   This predicts that Parascleraxis 
represents the ancestral Paraxis/Scleraxis gene that duplicated in the common ancestor 
of all vertebrates, sometime after the divergence of the agnathans from the group 
containing vertebrates and chondrichthyes.  
 The function of PARASCLERAXIS can be inferred by comparing its expression 
pattern to those of PARAXIS and SCLERAXIS. Parascleraxis expression has only been 
evaluated in one non-vertebrate chordate, the lamprey Petromyzon marinus, where it 
was found to be expressed in sclerotomal cells migrating into the medial fin from a 
somitic region surrounding the neural tube (Freitas et al., 2006). The expression of 
Parascleraxis in lamprey overlaps with that of Scleraxis in the catshark median fin, 
suggesting that the ancestral function of PARASCLERAXIS may be more similar to that 
of vertebrate SCLERAXIS. Drosophila parascleraxis (CG33557 / CG12648) is expressed 
during and after germband extension in 10 cells that were originally identified as midline 
CNS cells (Peyrefitte et al., 2001). These parascleraxis-expressing cells were 
subsequently re-identified as CNS-affiliated dorsal median (DM) cells of mesodermal 
origin (Kearney et al., 2004). DM cells are positioned along the ventral midline of the 
Drosophila embryo, at the borders of adjacent mesodermal segments. Upon germband 
retraction, DM cells extend processes laterally to join the muscle attachment sites in the 
body wall (Chiang et al., 1994), while expressing high levels of extracellular matrix 
proteins found in basement membranes, including laminin and collagen (Montell and 
Goodman, 1989; Lunstrum et al., 1988). Interestingly, DM cells are specified by signals 
from the midline CNS (Luer et al., 1997) and require wingless (WNT) signaling to be 
properly patterned (Zhou et al., 1997), both of which are also characteristics of 
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Paraxis/Scleraxis-expressing cells in vertebrate embryos. Together, the expression 
patterns of Parascleraxis in lamprey and Drosophila suggest a conserved role for the 
transcription factor in cells that regulate the extracellular matrix during muscle 
development. 
 
PARAXIS regulates the interaction of the paraxial mesoderm with its 
microenvironment. 
 Both invertebrate and vertebrate embryonic studies suggest that the function of 
PARAXIS/SCLERAXIS/PARASCLERAXIS throughout its evolutionary history has been 
to control the developmental patterning and integration of distinct mesodermal cell 
types. In vertebrates however, the function of PARAXIS in the regulation of the 
morphological state of cells from the paraxial mesoderm appears paradoxical.  In the 
mesenchymal tissue of the anterior PSM, PARAXIS is essential for MET during 
somitogenesis. During myogenesis, on the other hand, PARAXIS is expressed in the 
epithelial lips of the dermomyotome, where it appears to participate in EMT as MPCs 
delaminate and migrate into the limb bud.  However, if we also consider the importance 
of PARAXIS in regulating the morphology of myocytes in the forming myotome, a 
common theme emerges: the regulation of the expression of genes that mediate cell-cell 
and cell-ECM interactions, as well as the composition and stability of the ECM, is 
dependent upon PARAXIS.   
 It is well established that the cellular microenvironment provides signaling cues 
that influence cell behavior during development and disease. The composition of the 
pericellular ECM, and proteolytic remodeling of it, controls the microenvironmental 
signaling context that influences cell shape, motility, growth, survival and 
differentiation. The proper aggregation and differentiation of human pluripotent 
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embryonic stem cells, for example, is dependent upon integrin-mediated interactions 
with laminin in the ECM (Evseenko et al., 2009). Misregulation of cell–ECM interactions 
can also contribute to many diseases, including developmental, immune, hemostasis and 
degenerative and malignant disorders (Lukashev and Werb, 1998).  Here we 
demonstrate that PARAXIS is an important developmental regulator of this process.  The 
set of genes that are either up or down regulated by PARAXIS provides insights that may 
be applicable to understanding the broader regulation of ECM signaling. 
Of particular note, PARAXIS activates the expression of genes encoding receptors 
for ECM constituents, which must be organized into a basement membrane to provide a 
scaffold to which the epithelium can adhere during somitogenesis. PARAXIS is required 
for proper expression of Fap, which encodes a transmembrane protein that cooperates 
with integrins to increase fibronectin organization, and Itgav, encoding an integrin 
subunit that binds fibronectin, itself.  Interaction between the ECM and integrins are 
associated with changes in cell morphology and migration through the activation of Rho 
GTPases. The Rho GTPase family members, RAC1 and CDC42, have been implicated in 
the switch between epithelial and mesenchymal states of somitic cells. PARAXIS does 
not directly regulate Rho GTPase transcription, but may indirectly regulate their activity 
through its control of several integrins. The interaction of PSM cells with their 
microenvironment is known to be critical for the patterning of the somitic lineages (Rifes 
and Thorsteinsdottir, 2012), and PARAXIS functions to modulate this interaction. 
During epaxial myogenesis, PARAXIS again affects the expression of receptors 
for ECM molecules, this time in MPCs. Itga4 and Itga6, encoding integrin subunits 
expressed within the early myotome are downregulated in the absence of Paraxis. These 
integrins bind fibronectin and laminin, respectively, and are essential for myotome 
basement membrane formation and myocyte elongation. Myocyte-ECM interactions at 
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myotendinous junctions are also important for defining fiber-type specificity (Snow and 
Henry, 2009), and future studies will address whether PARAXIS expression is important 
for musculoskeletal system development after the initial formation of the myotome.  
The ECM, itself, is not the only constituent of the pericellular microenvironment. 
The ECM also harbors signaling molecules released from neighboring cells that can 
influence cell behavior. PARAXIS promotes hypaxial MPC migration through the 
activation of genes encoding receptors for morphogens, such as Met, and transcription 
factors that may regulate cytokine receptors, such as Lbx1. Taken together, our results 
point to a role for PARAXIS as a mediator of both MET and EMT. PARAXIS is activated 
in both morphogenetic contexts, yet performs the same essential function: regulating the 
cell’s ability to interact with proteins in the extracellular environment. 
 EMT is also required for the metastasis associated with cancer progression, and is 
therefore a heavily-studied process in the cellular context of the tumor (Thiery, 2002). 
Here, as in developmental EMT and MET, the control of ECM organization and ECM-
cell adhesion is critical to the transition between tissue states. For example, integrin 
α2β1, a laminin receptor, along with the fibronectin receptors integrins α4β1 and α5β1, 
direct the ECM remodeling and adhesion that allows melanoma cells to adopt a 
mesenchymal phenotype and migrate through the ECM surrounding the tumor (Etoh et 
al., 1992). Matrix metalloproteases, such as MMP9, are also important for pericellular 
ECM remodeling, as they function to degrade the basement membrane, promoting the 
invasion and motility potential of colon cancer cells (Lubbe et al., 2006). The 
upregulation of the MET receptor in hypoxic microenvironment conditions is also 
associated with breast cancer metastasis (Cooke et al., 2012). PARAXIS regulates the 
expression of integrins, integrin and ECM regulators, MMP9 and the MET receptor, and 
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and future studies may address the potential role for PARAXIS in the context of the 
tumor microenvironment. 
 Another heavily-studied microenvironment is the muscle satellite cell niche. 
Satellite cells are muscle-specific stem cells that become activated in response to signals 
indicating muscle damage. Satellite cells are derived from the dermomyotome (Gros et 
al., 2005), so the possibility exists that these cells retain Paraxis expression during 
developmental muscle maturation, and into adulthood. Satellite cell-environment 
interactions are critical to the colonization and maintenance of the satellite cell niche 
between the basal lamina and sarcolemma during myofiber development (Brohl et al., 
2012). Additionally, during adult muscle repair, satellite cells must be competent to 
respond to pericellular signals within their microenvironment that direct their activation 
and migration to the site of muscle damage (Yin et al., 2013). Here too, expression of the 
MET receptor is important, as it binds HGF released from the extracellular matrix and 
stimulates the activation and proliferation of quiescent satellite cells near damaged 
muscle (Tatsumi et al., 1998). Due to its regulation of receptors for extracellular signals 
common to both embryonic and adult muscle, PARAXIS may also prove to be an 
important regulator of the ability of satellite cells to respond to signaling factors and the 
ECM within their niche, affecting the efficiency of muscle repair in both normal and 
disease states.  
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